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ABSTRACT 
 
Optical microscopy, providing valuable biomedical insights at the cellular and organelle 
levels, has been widely recognized as an enabling technology. Mainstream optical 
microscopy technologies, including single-/multi-photon fluorescence microscopy and 
OCT, have demonstrated extraordinary sensitivities to fluorescence and optical scattering 
contrasts, respectively. However, the optical absorption contrast of biological tissues, 
which encodes essential physiological/pathological information, has not yet been fully 
assessable.  
The emergence of biomedical photoacoustics has led to a new branch of optical 
microscopy—OR-PAM. As a valuable complement to existing optical microscopy 
technologies, OR-PAM detects optical absorption contrasts with exquisite sensitivity (i.e., 
100%). Combining OR-PAM with fluorescence microscopy or optical-scattering-based 
OCT (or both) provides comprehensive optical properties of biological tissues. Moreover, 
OR-PAM encodes optical absorption into acoustic waves, in contrast to the pure optical 
processes in fluorescence microscopy and OCT, and thus provides background-free 
detection. The acoustic detection in OR-PAM mitigates the impacts of optical scattering 
on signal degradation and naturally eliminates possible interferences (i.e., crosstalks) 
between excitation and detection, which is a common problem in fluorescence 
microscopy due to the overlap between the excitation and fluorescence spectra and 
imperfect extinction of the filter. Unique for high-resolution imaging of optical 
absorption, OR-PAM has demonstrated broad biomedical applications in fields such as 
neurology, ophthalmology, vascular biology, and dermatology. My doctoral research 
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focuses on developments and biomedical applications of OR-PAM. 
The first part of my dissertation discusses the development of three generations of 
OR-PAM towards high-resolution, high-sensitivity, high-speed, and wide FOV in vivo 
imaging. In this section, I provide a comprehensive description of OR-PAM, including 
the principle, system design, system configuration, experimental procedures, laser safety, 
functional imaging scheme, and example biomedical applications at a variety of in vivo 
anatomical sites (i.e., skins, eyes and brains). 
The second part of my dissertation focuses on the application of OR-PAM in 
vascular biology, with an emphasis on neovascularization. In this section, I demonstrate 
longitudinal OR-PAM monitoring of the morphological (i.e., vessel diameter, length, 
tortuosity and volume) and functional (i.e., sO2) changes of angiogenic 
microenvironment at the capillary level, in both a non-disease TetON-HIF-1 transgenic 
mouse model and a cancer xenograft model in mouse ear. 
The last part of my dissertation focuses on the application of OR-PAM in 
neurology, with an emphasis on cortical stimulation, Alzheimer's disease, and ischemic 
stroke. In this section, I use label-free OR-PAM for both acute monitoring of 
microvascular responses to direct electrical stimulations of the mouse somatosensory 
cortex through a cranial opening and longitudinal monitoring of the morphological and 
functional changes of cortical vasculature in a transient middle cerebral artery occlusion 
mouse model. I also explore the potential of OR-PAM for transcranial monitoring of 
amyloid plaque growth in an AD mouse model. 
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I. INTRODUCTION 
1. Background and motivation*
The past two decades have witnessed a dramatic growth in biomedical applications of 
optical microscopy. Mainstream microscopy technologies—including, but not limited to, 
confocal microscopy, multiphoton microscopy, and OCT—have greatly benefited from 
advances in laser technology, fluorescent labeling, scanning mechanisms, and image 
acquisition. However, all these technologies rely on either optical scattering or 
fluorescent contrast and have fundamental limitation in assessing optical absorption 
properties of biological tissues.1  
 
The recent emergence of biomedical photoacoustics provides a promising solution 
for optical absorption imaging. In photoacoustics, biological tissues absorb short-pulsed 
or intensity-modulated optical irradiation, induce transient temperature rise, and further 
generate high-frequency ultrasonic waves. Photoacoustics provides an exquisite way to 
resolve the optical absorption distribution in biological tissue ultrasonically, leading to a 
new branch of optical microscopy—PAM. In PAM, the dual foci of optical excitation and 
ultrasonic detection are configured coaxially and confocally to maximize the imaging 
sensitivity. Thus, the lateral resolution of PAM is determined by the product of the two 
point spread functions. Taking advantage of the deep-focusing capability of ultrasound 
(ultrasonic scattering in tissues is 1,000 times weaker than optical scattering), AR-PAM 
with tight acoustic focusing and weak optical focusing has been developed for high-
resolution deep tissue imaging in the optical quasidiffusive or diffusive regime (Fig. 
1A).2, 3 Although having achieved great success, AR-PAM is inadequate for examining 
                                                 
* Modified with permission from S. Hu, K. Maslov, and L. V. Wang, “Three-dimensional optical-
resolution photoacoustic microscopy,” in Biomedical Optical Imaging Techniques: Design and 
Applications, J. M. Zavislan and R. Liang, Ed., Springer (under review). 
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the anatomy and function of biological tissues at the cellular or subcellular level. To fill 
this gap, we have developed OR-PAM (Fig. 1B), where the diffraction-limited optical 
focus predominates over the acoustic focus to improve the lateral resolution of PAM 
from 45 µm (acoustical) to 5 µm or even better (optical).4 As shown in Fig. 1, OR-PAM 
can clearly resolve single capillaries in an adult mouse brain through the intact skull (Fig. 
1D), while AR-PAM can only resolve cortical vessels thicker than 45 µm (Fig. 1C). 
However, the weak ultrasonic scattering allows AR-PAM to penetrate both the scalp and 
the skull, while OR-PAM requires the scalp to be removed. 
As a unique optical absorption microscopy technology and a valuable 
complement to the existing technologies, OR-PAM has demonstrated broad biomedical 
applications.5-11 Taking advantage of the strong optical absorption of endogenous 
hemoglobin, OR-PAM enables label-free, noninvasive, volumetric microvascular 
imaging down to single capillaries, providing both anatomical (such as vessel diameter, 
connectivity, and tortuosity) and functional (such as sO2 and blood flow) information.5-8, 
12 With the aid of exogenous molecular contrast agents, OR-PAM is also capable of 
molecular imaging.10 
3 
 
 
Fig. 1. Comparison of AR-PAM and OR-PAM. (A) Schematic of AR-PAM. (B) 
Schematic of OR-PAM. (C) AR-PAM image of the cortical vasculature in a living adult 
mouse with both the scalp and the skull intact. (D) OR-PAM image of the cortical 
vasculature in a living adult mouse with the scalp removed and the skull intact. Scale bars: 
1 mm. 
 
2. Dissertation outline 
In Chapter II, I reviewed the development of three generations of OR-PAM, towards 
high-resolution, high-sensitivity, high-speed, and wide FOV in vivo imaging. Our G1 
OR-PAM designed and implemented in 2007 has demonstrated, for the first time, in vivo, 
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label-free, noninvasive imaging of single capillaries.4 Excellent spatial resolution (5 μm 
lateral and 15 μm axial) and adequate tissue penetration (>0.7 mm) have found G1 OR-
PAM broad biomedical applications in such fields as neurology,10, 13 ophthalmology,8 and 
vascular biology5-7 since its invention. However, the acoustic detection in G1 OR-PAM 
suffers significant loss.10 Moreover, the G1 system could cover only a small FOV within 
a reasonable acquisition time because translating the living object for scanning must be 
slow enough to avoid possible disturbance to the object. In 2009, we invented G2 OR-
PAM with improved detection sensitivity and imaging speed. In G2 OR-PAM, we 
designed a novel optical-acoustic combiner, which improves the detection sensitivity by 
18.4 dB over the G1 system. Moreover, the optical-fiber-based light delivery allows 
scanning the imaging head rather than the living object, thereby enabling fast in vivo 
imaging (5 times as fast as the G1 system) over a large FOV (centimeters along the 
lateral dimensions). More valuably, instrument-scanning extends the scope of G2 OR-
PAM to objects that are impractical to move mechanically for scanning (e.g., humans). 
Although G2 OR-PAM has a significant improvement on imaging speed over the G1 
system, its maximum B-scan rate (<3 frames/s) is still far from real time. Such imaging 
speed is not yet adequate to catch acute microhemodynamics in such as neurovascular 
coupling. Recently, we developed G3 OR-PAM with combined optical-scanning and 
mechanical-scanning. While maintaining the large FOV made possible by mechanical 
scanning, G3 OR-PAM offers the option of real-time optically scanning a small ROI to 
visualize acute microhemodynamics and cell trafficking. Moreover, optical scanning can 
be potentially hybrid with mechanical scanning for high-speed, wide FOV imaging. 
Chapter III focuses on the application of OR-PAM in vascular biology, with an 
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emphasis on neovascularization. There is a lack of methodology that combines 
conditional genetic approaches with longitudinal, noninvasive, label-free microvascular 
imaging for the study of adult neovascularization. In this section, we successfully applied 
OR-PAM to longitudinally study engineered adult neovascularization in a disease-free 
TetON-HIF-1 transgenic mouse model, wherein DOX induction of an oxygen insensitive 
HIF-1 mutant was targeted to basal keratinocytes using a keratin 5-rtTA driver. OR-PAM 
produced longitudinal images of the same microvascular network undergoing capillary 
angiogenesis and trunk vessel remodeling over 60-day continuous angiogenic stimulus 
with and without perturbations to the angiogenic pathways (e.g., VEGF receptor 
immunoblocking and VEGF gene deletion). Moreover, the image extraction capability of 
OR-PAM enabled quantitatively analyzing the sensitivity of differential microvessel 
subset (capillary vs. trunk vessel) to antiangiogenesis therapy and the stage-specific 
resistance to that treatment. OR-PAM also serially imaged capillary and terminal 
arteriolar and venular regression following HIF-1 withdrawal, providing unprecedented 
real-time images of luminal constriction and microvessel dropout. The excellent 
agreement between data from the noninvasive, in vivo OR-PAM and the “gold standard”, 
invasive, ex vivo histology procedures validated, for the first time, the accuracy of OR-
PAM for quantitative, functional microvascular imaging. As a valuable extension, I also 
reported some preliminary study on a disease model with cancer xenografts in mouse ears. 
Chapter IV focuses on the application of OR-PAM in neurology, with an 
emphasis on cortical stimulaton, Alzheimer's disease, and ischemic stroke. First, we 
explored the potential of OR-PAM for longitudinal monitoring of amyloid plaque growth 
in an AD mouse model. Validation using conventional fluorescence microscopy and 
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multiphoton microscopy shows that OR-PAM has sufficient sensitivity and spatial 
resolution to identify amyloid plaques in living mouse brains through a cranial window. 
In addition, with dual-wavelength OR-PAM, the 3-D morphology of amyloid plaques and 
the surrounding microvasculature are imaged simultaneously without angiographic 
contrast agents. However, transcranial imaging of amyloid plaque growth requires further 
optimization of imaging parameters and improvements in the optical absorption of 
amyloid-specific dyes. Second, we demonstrated the potential of OR-PAM in the field of 
neurovascular coupling by studying microvascular responses to direct electrical 
stimulations of the mouse somatosensory cortex. We observed two forms of responses 
(vasoconstriction and vasodilatation) and the stimulation-variation-induced transition 
between these two forms. We also observed a marked correlation between the current-
dependent responses of two daughter vessels bifurcating from the same parent vessel. 
Statistical analysis of twenty-seven vessels from three different animals further 
characterized the spatial-temporal features and the current dependence of the 
microvascular response. As a valuable extension, I also reported some preliminary study 
on ischemic stroke in a transient MCA occlusion mouse model.  
Finally, in the Chapter V, the summary of my dissertation work is presented.  
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II. OR-PAM: SYSTEMS AND EXAMPLE BIOMEDICAL APPLICATIONS 
1. G1 OR-PAM*
1.1 Introduction 
 
The advantages of PAM over traditional optical and ultrasonic imaging include primarily 
the detection of endogenous optical absorption contrast at ultrasonic resolutions.3, 14 In 
PAM, a pulsed laser beam is weakly focused into the biological tissue to produce 
emission of ultrasonic waves due to thermal expansion of the medium caused by 
absorbed laser radiation. The ultrasonic waves are then detected with a focused ultrasonic 
transducer to form high-resolution volumetric images. Among the existing photoacoustic 
imaging technologies, the spatial resolutions depend almost solely on the ultrasonic 
parameters including the frequency and the NA. For example, in the recently developed 
dark-field confocal PAM, a lateral resolution of 50 µm was achieved with a center 
frequency of 50 MHz and an NA of 0.44.2 This resolution is adequate for many 
biomedical applications.14, 15 However, to resolve smaller structures such as capillaries, 
which are 4–9 µm in diameter,16 higher spatial resolution is required. 
If both the lateral and axial resolutions are provided ultrasonically, the imaging 
penetration is limited by the frequency-dependent ultrasonic attenuation in tissue. For 
example, a 5-µm lateral resolution requires an ultrasonic center frequency greater than 
300 MHz. At such a high frequency, the ultrasonic attenuation (~20 dB/mm in water and 
~80 dB/mm in tissue) limits the penetration depth to ~100 µm, which is less than that of 
optical confocal microscopy. An alternative is to use fine optical focusing to provide the 
lateral resolution while the axial resolution is still derived from time-resolved ultrasonic 
                                                 
* Reprinted with permission from K. Maslov†, H. F. Zhang†, S. Hu†, and L. V. Wang, "Optical-
resolution photoacoustic microscopy for in vivo imaging of single capillaries," Opt. Lett. 33, 929–
931 (2008). † Authors contributed equally to this work. 
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detection. We refer to this alternative technology as OR-PAM. Although having a 
comparable depth penetration limit with existing high-resolution optical imaging 
modalities (including optical confocal microscopy, two-photon microscopy, and OCT), 
OR-PAM is primarily sensitive to optical absorption contrast, whereas the other 
modalities are dominantly sensitive to optical scattering or fluorescence contrast. 
 
1.2 Materials and Experiments 
Our OR-PAM system (Fig. 2) employs optical focusing to achieve µm-level lateral 
resolution. A dye laser pumped by an Nd:YLF laser is used as the irradiation source. 
Laser pulses (pulse duration: 7 ns) from the dye laser are spatially filtered by a 25-µm-
diameter pinhole. The pinhole is then imaged to a diffraction-limited focal spot with a 
diameter of 3.7 µm by an objective lens (NA: 0.1; depth of focus: ~40 µm). The laser 
pulse energy after the objective lens is measured to be 100 nJ. Ultrasonic focusing is 
achieved through a plano-concave lens (radius of curvature: 5.2 mm; aperture: 6.4 mm; 
NA in water: 0.46) and the ultrasonic focal diameter is 27 µm. The optical objective lens 
and the ultrasonic transducer are configured coaxially and confocally as shown in Fig. 2. 
Combination of time-resolved detection of the photoacoustic waves with a 2-D 
raster scanning along the x-y plane generates a volumetric image,15 which can be viewed 
through direct volumetric rendering, B-scan images, or MAP images.15  
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Fig. 2. Schematic of the OR-PAM system. 
 
1.3 Results and Discussion 
The imaging depth of the OR-PAM system was measured by imaging two horse hairs 
(diameter: 200 µm) separately placed above and below a piece of freshly harvested rat 
scalp. An OR-PAM image (Fig. 3A) was acquired with 32 times signal averaging at the 
optical wavelength of 630 nm. Both hairs are clearly visible. The B-scan image (Fig. 3B) 
shows that the bottom hair is 700 µm deep in the tissue. Therefore, the imaging 
penetration limit is at least 700 µm. 
The axial resolution was estimated to be 15 µm based on the measured transducer 
bandwidth (100 MHz in receiving-only mode) and the speed of sound in tissue (1.5 
mm/µs). The lateral resolution of the OR-PAM system was experimentally estimated by 
imaging an Air Force resolution test target (USAF-1951, Edmund) immersed in an 
optically clear medium. Images were acquired at the optical wavelength of 590 nm 
without signal averaging. In Fig. 3C, the highlighted well-resolved bars (group 6, element 
5) have gaps of 4.9 µm (spatial frequency: 102 mm-1; modulation transfer function value: 
0.65). Other pairs of spatial frequency and modulation transfer function values are 64 
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mm-1 with 0.95 and 80 mm-1 with 0.8. Nonlinearly fitting the modulation transfer 
function followed by extrapolation yields a lateral resolution of 5 µm, which is 30% 
greater than the diffraction limit of 3.7 µm. As a further illustration of the lateral 
resolution, an MAP image of a 6-µm-diameter carbon fiber immersed in water is shown 
in Fig. 3D. The mean FWHM value of the imaged fiber is estimated to be 9.8 µm, which 
is 3.8 µm wider than the fiber diameter and hence in agreement with the 5-µm resolution. 
Since the lateral resolution is expected to deteriorate with imaging depth due to optical 
scattering, a 6-µm-diameter carbon fiber covered by a 0.2-mm-thick nude mouse ear is 
imaged. The photoacoustic amplitude profile of a cross section of this carbon fiber is 
shown in Fig. 3E. The FWHM value of the imaged fiber is estimated to be 10 µm. Hence 
OR-PAM maintains ~5 µm lateral resolution in tissue up to at least 0.2 mm depth.  
 
Fig. 3. Imaging depth and lateral resolution of the OR-PAM system. (A) MAP image of 
two horse hairs placed above and below a piece of rat skin. (B) B-scan image at the 
location marked by the dashed line in (A). (C) MAP image of an Air Force resolution test 
target group 6. (D) MAP image of a 6-µm-diameter carbon fiber. (E) Cross-sectional 
profile of the 6-µm-diameter carbon fiber. 
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The major optical absorbers in the visible spectral range in biological tissue 
include deoxyhemoglobin and oxyhemoglobin. Consequently, PAM, acting as a sensitive 
blood detector with high contrast and specificity, is suitable for imaging the volumetric 
morphology of subcutaneous microvasculature in vivo.  
We applied the OR-PAM to image the microvasculature in an ear of a nude 
mouse (Hsd:Athymic Nude-Foxn1NU, Harlan Co.; body weight: 20 g) in vivo at the 
optical wavelength of 578 nm. All experimental animal procedures were carried out in 
conformity with the laboratory animal protocol approved by the School of Medicine 
Animal Studies Committee of Washington University in St. Louis. Nude mouse ears 
(thickness: ~300 µm) have well-developed vasculature and have been widely used to 
study tumor angiogenesis and other microvascular diseases.17, 18 During image acquisition, 
the animal, warmed by an infrared lamp, was kept motionless using a breathing 
anesthesia system (E-Z Anesthesia, Euthanex). Unlike the published study,19 no optical 
clearing agent was applied to the skin surface. An area of 1×1 mm2 was scanned with a 
step size of 1.25 µm without signal averaging. The scanning time for a complete 
volumetric dataset was ~10 min. After data acquisition, the animal recovered naturally 
without observable laser damage. 
The OR-PAM image of the microvasculature (Figs. 4A and 4B) agrees with the 
photograph (Fig. 4C) taken with a transmission optical microscope at a 4× magnification; 
however, small vessels are only observed in the OR-PAM images. The mean ratio of the 
photoacoustic amplitudes between the blood vessels and the background is 20:1, which 
demonstrates a high endogenous optical-absorption-based contrast. Some vessels, such as 
the vessel labeled with CL in Fig. 4A, have diameters of ~5 µm and hence most probably 
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are single capillaries. A volumetric rendering of the photoacoustic data (Fig. 4B) shows 
the 3D spatial positions and connectivity of the blood vessels. For example, at the center 
of the circle in Fig. 4B, the small-diameter vessel invisible in the MAP image in Fig. 4A 
is clearly seen ~100 µm above the lager vessel. In addition, vessel branching is clearly 
observed. Therefore, OR-PAM is able to image single capillaries in vivo with endogenous 
contrast due to the optical absorption of hemoglobin. 
 
1.4 Conclusion 
The capability of OR-PAM to image physiological and pathological changes in 
capillaries and other microvessels has potentially broad applications. Possible 
applications include microscopic imaging of vasodilation and vasoconstriction in stroke, 
tumor angiogenesis, tumor extravasations, and tumor metabolic rate of oxygen 
consumption. Mouse ears were chosen as the initial organ to test OR-PAM because in 
this case transmission optical microscopy can be used to validate some of our results. 
Since OR-PAM operates in reflection mode, it can be applied to many other anatomical 
sites. 
Several technical improvements can be made in the future. First, images can be 
acquired by scanning the optical-acoustic dual foci instead of the animal and the water 
tank to reduce possible motion artifacts. Second, it is possible to scan only the optical 
focus within the acoustic focusing area to reduce the image acquisition time by at least an 
order of magnitude. Third, besides endogenous contrast from hemoglobin, targeted 
exogenous contrast agents, such as ICG and nanoparticles, can be employed for in vivo 
molecular imaging.20 Fourth, the acoustic coupling cube in the current design can be 
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improved to transmit photoacoustic waves much more efficiently (without transformation 
from p-waves into sv-waves) so that the SNR can be improved by at least 14 dB. In 
addition, applying acoustic antireflection coating on the lens should further increase the 
SNR by another 10 dB. 
When the optical focus is 100 µm below the tissue surface, the surface optical 
fluence is close to the ANSI safety limit (20 mJ/cm2 in the visible spectral region).21 
Although the ANSI standards regulate only the surface fluence, we compute here the 
spatial peak optical fluence at the focus in water, which is 500 mJ/cm2. Even this focal 
fluence is still less than the damage threshold experimentally observed in small animals.19 
We believe that the optical fluence can be reduced without affecting the SNR after the 
aforementioned improvements are implemented. 
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Fig. 4. Microvasculature in a nude mouse ear. (A) In vivo OR-PAM image. (B) 3D 
pseudocolor visualization of the vasculature. (C) Photograph taken with transmission 
optical microscopy. CL: capillary; SG: sebaceous gland. 
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2. G2 OR-PAM*
2.1 Introduction 
 
OR-PAM, which can detect both physiologically specific endogenous contrasts (e.g., 
HbO2 and HbR7) and molecular-specific exogenous contrasts (e.g., congo red labeled 
amyloid plaques10) with cellular or subcellular spatial resolution, has found broad 
biomedical applications in such fields as neurology,10 ophthalmology,8, 11 and vascular 
biology. In our G1 OR-PAM, the optical-acoustic combiner  suffers significant acoustic 
loss.10 Moreover, the G1 system could cover only a small FOV within a reasonable 
acquisition time because translating the living object for scanning must be slow enough 
to avoid possible disturbance to the object. Here, we report our G2 OR-PAM with 
improved detection sensitivity and imaging speed. In G2 OR-PAM, we have designed a 
novel optical-acoustic combiner, which improves the detection sensitivity by 18.4 dB 
over the G1 system. Moreover, the fiber-based light delivery allows scanning the imaging 
head rather than the living object, thereby enabling fast in vivo imaging (5 times as fast as 
the G1 system) over a large FOV (centimeters along the lateral dimensions). More 
valuably, instrument-scanning extends the scope of G2 OR-PAM to objects that are 
impractical to move mechanically for scanning (e.g., humans). 
 
2.2 Materials and Experiments 
Our G2 OR-PAM system (Fig. 5) employs a wavelength-tunable laser system, consisting 
of a diode-pumped solid-state laser (INNOSLAB, Edgewave) and a dye laser (CBR-D, 
Sirah), for photoacoustic irradiation at single or multiple optical wavelengths. A mirror-
                                                 
*  S. Hu†, K. Maslov†, and L. V. Wang, “Second-generation optical-resolution photoacoustic 
microscopy with improved sensitivity and speed,” (Ready to submit). † Authors contributed 
equally to this work. 
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loaded piezo actuator (P-287, Physik Instrumente) is incorporated into the cavity of the 
dye laser for fast wavelength tuning (0.3 nm/ms). The output laser beam (pulse width: 7 
ns) is reshaped by an iris (ID25SS, Thorlabs; the aperture size is set to 2 mm), and then 
focused by a condenser lens (LA1131, Thorlabs) before passing through a 50-µm pinhole 
(P50C, Thorlabs). The pinhole is positioned slightly away from the focus of the 
condenser lens (focal diameter: 18 µm) to match the diameters of the pinhole and the 
fundamental-mode beam for effective spatial filtering. The filtered beam is attenuated by 
a neutral density filter (NDC-50C-2M, Thorlabs) and launched into a single-mode fiber 
coupler (F-91-C1, Newport). The output of the single-mode fiber (P1-460A-FC-2, 
Thorlabs) is collimated by a microscope objective (RMS4X, Thorlabs), reflected by a 
stationary mirror, and fills the back aperture of another identical objective (imaging 
objective) to achieve nearly diffraction-limited optical focusing. A beam sampler 
(BSF05-A, Thorlabs) and a photodiode are inserted between the collimation objective 
and the stationary mirror to monitor the fluctuation in laser intensity. Different from the 
G1 OR-PAM system (solid-boundary inset in Fig. 5), where two right-angle prisms 
sandwich a thin layer of silicone oil for acoustic-optical coaxial alignment,4 G2 OR-PAM 
replaces the lower right-angle prism with a rhomboid prism (NT49-419, Edmund Optics) 
to enhance the detection sensitivity (as discussed later). An acoustic lens (NA: 0.5) is 
ground in the bottom of the rhomboid prism, and provides an acoustic focal diameter of 
43 µm at the 50-MHz central frequency of the ultrasonic transducer (V214-BB-RM, 
Olympus-NDT). The optical and acoustic foci are aligned confocally to maximize the 
detection sensitivity. The acoustic lens is submerged in a water-filled Petri dish (9 cm in 
diameter) for acoustic coupling. An imaging window is opened in the bottom of the Petri 
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dish and sealed with a polyethylene membrane for optical and acoustic transmission. 
Two-dimensional raster scanning of the imaging head (dashed box in Fig. 5), in 
combination with time-resolved acoustic detection, provides volumetric imaging of tissue 
optical absorption. A charge-coupled device camera (MEDSI3, Meade Instruments) is 
added to view the imaging region through the reverse path of the optical illumination. 
 
Fig. 5. Schematic of G2 OR-PAM. The solid-boundary inset shows the configuration of 
the optical-acoustic combiner in the G1 OR-PAM system. ConL: condenser lens; ND: 
neutral density; FC: fiber collimator; SMF: single-mode fiber; CCD: charge-coupled 
device; BS: beam splitter; PD: photodiode; CorL: correction lens; RAP: right-angle 
prism; SO: silicone oil; RhP: rhomboid prism; US: ultrasonic transducer. 
 
2.3     Results and Discussion 
In the G1 system, the obliquely  incident (45°) acoustic signal is reflected by a single 
solid-liquid interface (Fig. 5), where the energy of the longitudinal acoustic wave is 
coupled into both shear and longitudinal waves.22 According to the boundary conditions 
and Snell’s Law,23 85.1% of the incident acoustic energy is transformed from 
longitudinal mode to shear mode at the interface, and only 0.8% of the acoustic energy 
remains in longitudinal mode. The second inclined surface provided by the rhomboid 
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prism in the G2 system is able to transform 97.2% of the shear-wave energy back into 
longitudinal waves, to which the ultrasonic transducer is much more sensitive. In 
comparison to the combiner in the G1 system, the new design can theoretically result in a 
20-dB increase in the detected longitudinal-wave energy, which was expected to provide 
much higher detection sensitivity. As an experimental validation, we imaged the same 6 
µm carbon fiber using both the G1 and G2 systems (Fig. 6). Our results show that, at the 
same optical irradiation level (6.5 nJ/pulse), the SNR of the G2 system was 18.4 dB 
higher than that of the G1 system. The actual improvement in SNR is in good agreement 
with the theoretical estimation. 
 
Fig. 6. Sensitivity comparison of the G1 and G2 OR-PAM systems by imaging the same 
carbon fiber at the same laser fluence level. PA: photoacoustic. 
 
In the G2 OR-PAM system, the NAs of both microscope objectives are 0.1 in air. 
However, the imaging objective is compensated for water immersion by the correction 
lens, so the effective NA of the imaging objective is 0.133. Thus, the theoretical lateral 
resolution (measured in FWHM) of the G2 system (i.e., the diffraction-limited optical 
focal diameter) is calculated to be 2.14 µm at 570 nm. The lateral resolution of the G2 
system was experimentally quantified by imaging an Air Force resolution test target 
(04TRN003, CVI Melles Griot) at 570 nm. As shown in Figs. 7A and 7B, the G2 system 
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is capable of resolving the finest line pairs (Group 7, Element 6) with a modulation depth 
of 62%. Modulation transfer function analysis4 reveals a cutoff spatial frequency (i.e., the 
frequency at which the modulation depth reaches zero) of  390 cycles/mm, which 
corresponds to a FWHM resolution of 2.56 µm. The experimentally measured lateral 
resolution is slightly worse than the diffraction-limit estimate, which is likely due to 
imperfect aberration compensation. The maximum tissue penetration was also 
experimentally quantified by inserting a 250-µm-diameter black needle obliquely into a 
living mouse leg (Hsd:Athymic Nude-Foxn1NU, Harlan). As shown in Fig. 7C, the G2 
system can clearly image the needle down to 1.2 mm beneath the tissue surface. 
Compared with the 0.7-mm ex vivo penetration of G1 OR-PAM at 630 nm (where blood 
absorption is ~25 times lower than at 570 nm), the 1.2-mm in vivo penetration of G2 OR-
PAM at 570 nm is much deeper, due to the enhanced detection sensitivity. 
 
Fig. 7. Spatial resolution and in vivo tissue penetration of the G2 OR-PAM. (A) OR-
PAM image of an Air Force resolution test target. (B) The cross-sectional profile of the 6 
elements in group 7 of the resolution target, as indicated by the red dashed line in (A). 
(C) OR-PAM image of a black needle inserted obliquely in a living mouse leg. PA: 
photoacoustic. 
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The much improved system performance enables G2 OR-PAM to image a large 
FOV with single RBC resolution and sensitivity. Figure 8 shows the whole-ear vascular 
anatomy in a 10-week-old living nude mouse (Hsd:Athymic Nude-Foxn1NU, Harlan) 
imaged by OR-PAM at 570 nm. The laser pulse energy after the imaging objective was 
measured to be 80 nJ. Since the optical focus is 150-µm beneath the skin surface, the 
surface laser fluence is 22 mJ/cm2, which is close to the ANSI safety limit (20 mJ/cm2 in 
the visible spectral region). Densely packed capillary beds as well as discrete RBCs 
traveling along capillaries are clearly resolved. The typical acquisition time of such a 
single-wavelength, bidirectionally scanned image (image size: 7.8 mm × 10 mm; step 
size: 2.5 µm × 2.5 µm) is 70 min, which is 5 times as fast as that for the G1 system. The 
B-scan rate of 7.8 mm across is 0.95 Hz. Because the absorption coefficient of blood at 
570 nm is estimated to be 240.6 cm-1 and the SNR within the dual foci is 42.7 dB, the 
sensitivity of G2 OR-PAM in terms of the noise-equivalent absorption coefficient is 1.8 
cm-1. With dual-wavelength measurements (561 nm and 570 nm), G2 OR-PAM can also 
reveal the sO2 of the whole-ear vasculature at the capillary level (Fig. 9). The image 
acquisition time of such a detailed sO2 map is 80 min (image size: 10.6 mm ×10 mm; step 
size: 2.5 µm × 5 µm). Note that the scanning speed of the G2 OR-PAM system can be 
further improved by using a high-repetition-rate laser. Our recent experimental results 
show another 3-fold improvement in speed with a 40-kHz pulsed laser.  
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Fig. 8. OR-PAM of vascular anatomy in a living mouse ear. Insert shows a densely 
packed capillary bed and individual red blood cells traveling along a capillary. 
 
 
Fig. 9. Dual-wavelength (561 nm and 570 nm) OR-PAM of sO2 in a living mouse ear. 
 
Taking advantage of the time-resolved acoustic detection, G2 OR-PAM can 
clearly differentiate skull vessels and cortical vessels in living mice. As a validation, we 
perfused the skull vessels in a 3-month-old Swiss Webster mouse (Hsd:ND4, Harlan) 
with methylene blue dye. At 570 nm, both the methylene-blue-perfused skull vessels and 
the RBC-perfused cortical vessels provide strong photoacoustic signals, which are shown 
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in different colors in the depth-encoded image (Fig. 10A). At 650 nm, where hemoglobin 
has very low optical absorption (~40 times lower than at 570 nm), only the skull vessels 
remain visible (Fig. 10B), which show perfect agreement with the green-encoded skull 
vasculature in Fig. 10A. Note that the depth range (0–375 µm) in Fig. 10A does not 
reflect the maximum cortical penetration of G2 OR-PAM through the intact skull, 
because the maximum signal rather than the deepest signal is projected along each A-line. 
 
Fig. 10. Transcranial OR-PAM of a living adult mouse brain. (A) depth-encoded MAP 
image of both methylene-blue-perfused skull vasculature and blood-perfused cortical 
vasculature at 570 nm. (B) MAP image of methylene-blue-perfused skull vasculature at 
650 nm. PA: photoacoustic. 
     
2.4 Conclusion 
We have developed G2 OR-PAM with high-sensitivity acoustic detection and instrument-
scanning. Compared with G1 OR-PAM, the detection sensitivity and the scanning speed 
are improved by 18.4 dB and 5-fold, respectively. Large-FOV, volumetric microscopy of 
vascular anatomy and sO2 are demonstrated. The imaging speed can be further improved 
without compromising the FOV by combining optical and mechanical scanning. 
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3. G3 OR-PAM*
Recently, we developed a prototype of G3 OR-PAM with combined optical-scanning and 
mechanical-scanning (Fig. 11). To implement the optical scanning, we replaced the 
stationary mirror in the mechanical-scanning-based G2 system with a 2-D fast steering 
mirror.  
 
 
Fig. 11. Schematic of G3 OR-PAM. ConL: condenser lens; ND: neutral density; FC: 
fiber collimator; SMF: single-mode fiber; CCD: charge-coupled device; BS: beam 
splitter; PD: photodiode; CorL: correction lens; RAP: right-angle prism; SO: silicone oil; 
RhP: rhomboid prism; US: ultrasonic transducer. 
   
As a proof-of-principle demonstration, we first mechanically scanned the entire 
ear of a nude mouse (Hsd:Athymic Nude-Foxn1NU, Harlan Co.) to create a site map (Fig. 
12A), and then a ROI containing a single capillary was identified and optically scanned 
for 100 volumetric frames to visualize the flow of individual RBCs along the targeted 
capillary with relatively low laser fluence (Fig. 12B) and high fluence (Fig. 12C), 
                                                 
* S. Hu, et. al., Preliminary data. 
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successively. It is interesting that, at low laser fluence, three representative optical-
scanning frames show different RBC distributions, which indicates an undergoing 
capillary flow. However, with increased laser fluence, different frames show identical 
RBC distributions, suggesting a laser-induced capillary clot. Note that other acute 
hemodynamics (e.g., vasomotion and vasodilation) at the capillary level are also expected 
to be visible to G3 OR-PAM.  
This demonstration projects the great potential of G3 OR-PAM in better 
understanding microvascular functioning and extracting regional oxygen metabolism, 
which may revolutionize the study of vascular biology and neurovascular coupling. 
However, the current design and operation of G3 OR-PAM requires further optimization. 
The optical-acoustic combiner used here is not ideal for optical scanning, because the 
relatively long optical path within the bulky combiner may induce noticeable optical 
aberrations. Moreover, the tightly focused acoustic lens (focal diameter: 43 µm) seriously 
limits the FOV of optical scanning. A future refinement is to eliminate the optical-
acoustic combiner by using a high-frequency wide-band ring transducer (center 
frequency: 43 MHz; 6 dB round-trip bandwidth: 36 MHz; f-number: 1.5; diameter of the 
inner hole: 1.92mm). The center hole in the transducer is ideal for aberration-free 
confocal alignment of optical irradiation and acoustic detection. Moreover, the increased 
acoustic focal diameter (75 μm) enlarges the FOV of optical scanning. Another future 
direction is to hybrid optical scanning with mechanical scanning for high-speed, wide 
FOV imaging. 
25 
 
 
Fig. 12. Real-time OR-PAM of capillary flow in a living mouse ear. (A) Large FOV 
mechanical scanning of the entire ear. Green dashed box: ROI containing the capillary to 
be optically scanned. (B) and (C) were acquired with low and high laser fluence, 
respectively. In both (B) and (C), the left column is the mechanical scanning of the ROI, 
wherein the white arrows indicate the same capillary to be optically scanned. The right 
column contains three representative maximum-amplitude-projected optical-scanning 
frames of the capillary.  
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4. Example biomedical applications at a variety of in vivo anatomical sites 
4.1 Noninvasive label-free imaging of acute microhemodynamics in mouse ears*
4.1.1. Introduction 
 
The microcirculation plays a central role in the regulation of the metabolic, hemodynamic 
and thermal state of the individual.24 Many major diseases25-31 are manifest in the 
microcirculation before they are clinically evident, which provides a potential early 
perspective on the origin and progression of such diseases. However, established clinical 
imaging modalities such as CT, MRI, PET, and ultrasonography lack the resolution 
needed for microvascular imaging.32 Even with iodine contrast, x-ray imaging cannot 
image single capillaries. Thus, optical microscopy has been widely used to assess the 
cellular and molecular features of the microcirculation. IVM, for example, is the gold 
standard for microcirculation studies. It allows quantification of vessel count, diameter, 
length, density, permeability, and blood flow velocity. Nevertheless, to observe 
capillaries in vivo, IVM generally requires trans-illumination and surgical preparation,33 
restricting its application to limited anatomical sites and interfering with the intrinsic 
microcirculatory function. Additionally, conventional IVM lacks depth resolution that is 
crucial for extracting the 3-D microvascular morphology. Confocal microscopy34 and 
two-photon microscopy,35 noninvasive and possessing excellent depth-sectioning 
capability, have difficulty in detecting microvessels without exogenous fluorescent agents, 
which, although having greatly facilitated laboratory research, are still facing challenges 
in clinical translations.36 OPS imaging permits noninvasive microvascular imaging 
without the use of fluorescent dyes,37 paving its way to the bedside. However, OPS 
                                                 
* Reprinted with permission from S. Hu, K. Maslov and L. V. Wang, "Noninvasive label-free 
imaging of microhemodynamics by optical-resolution photoacoustic microscopy," Opt. Express 
17(9), 7688-7693 (2009). 
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provides no depth information and lacks the measurement consistency38 required for 
longitudinal studies.  
To overcome these difficulties, we have developed OR-PAM, a noninvasive 
volumetric microscopy technology capable of detecting the physiologically specific 
absorption signatures of endogenous chromophores, such as hemoglobin, in vivo. The 
ability to introduce hemoglobin absorption contrast into the optical-resolution 
microscopy regime leads to an extremely versatile technique for microcirculation studies, 
without the limitations of fluorescent labeling and invasiveness. Besides the 
morphological parameters, such as vessel count, diameter, and length, OR-PAM also 
validates the quantification of important functional parameters, including HbT and sO239, 
40 down to the capillary level. Multiple attractive features make OR-PAM a valuable tool 
for microcirculation studies (Table 1), which is demonstrated below by noninvasively 
monitoring microhemodynamic activities in vivo.  
 
Table 1. Comparison of modern high-resolution microvascular imaging techniques. CM: 
confocal microscopy; TPM: two-photon microscopy. 
Modality 3D morphology 
sO2 
quantification 
HbT 
quantification 
Imaging 
contrast 
Working 
manner 
IVM  †  Scattering, fluorescence Invasive 
CM    Scattering, fluorescence Noninvasive 
TPM    Fluorescence Noninvasive 
OPS    Absorption‡ Noninvasive 
OR-
PAM    Absorption Noninvasive 
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† IVM requires adopting Raman spectroscopy for sO2 measurement.  
‡ Different from OR-PAM, OPS provides negative absorption contrast. 
 
4.1.2. Methods 
Our OR-PAM system employs nearly diffraction-limited optical focusing with bright 
field illumination to achieve 5-µm lateral resolution. The axial resolution is calculated to 
be ~15 µm, based on the transducer bandwidth and the speed of sound in tissue. The B-
scan rate over a 1-mm distance is ~1 frame per second. The detailed system design is 
described in.41 Through time-resolved ultrasonic detection and 2-D raster scanning along 
the transverse plane, the OR-PAM system records the complete 3-D microvasculature of 
the tissue, which can be viewed in MAP image (Fig. 13a) or direct volumetric rendering 
(Fig. 13b). All experimental animal procedures were carried out in conformance with the 
laboratory animal protocol approved by the School of Medicine Animal Studies 
Committee of Washington University in St. Louis. 
100 µm
Optical absorption
Min Max
a b
 
Fig. 13. A representative microvascular network in a nude mouse ear imaged in vivo by 
OR-PAM. (a) MAP image. (b) 3D morphology. 
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4.1.3. Results and Discussion 
Vasodilation, an important vessel activity in regulating tissue oxygen delivery, refers to 
an increase in vessel diameter. In contrast, vasomotion is a periodic oscillation of the 
vessel diameter and is not a consequence of the heart beat, respiration, or neuronal 
input.42 Substantive experimental work has suggested that vasomotion might serve as a 
protective mechanism under conditions of ischemia and be an important indicator of 
cardiovascular events,43 but its physiological role and the underlying mechanism remain 
elusive.44  
To explore vasomotion and vasodilation in response to tissue oxygen variation, 
first we selected a 1-mm-by-1-mm region in a nude mouse ear. Structural and sO2 images 
(Fig. 14) were acquired by a dual-wavelength measurement under systemic normoxia. 
According to the sO2 value, we selected an arteriole-venule pair (A1 and V1 in Fig. 14b), 
which were almost perpendicular to the B-scan direction (marked by the yellow dashed 
line in Fig. 14b). In this case, the B-scan image delineates the actual vessel cross section.  
50 µm
0.6
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sO
2
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Fig. 14. Structural and functional microvascular imaging by OR-PAM in a nude mouse 
ear in vivo. (a) Structural image acquired at 570 nm. (b) Vessel-by-vessel sO2 mapping 
based on dual-wavelength (570 nm and 578 nm) measurements. The calculated sO2 
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values are shown in the color bar. PA: photoacoustic signal amplitude. A1: a 
representative arteriole; V1: a representative venule. Yellow dashed line: the B-scan 
position for Fig. 15.  
 
Then, we repeated the selected B-scan continuously for seventy minutes, during 
which the physiological state of the animal was switched between systemic hyperoxia 
and hypoxia (indicated by the red and blue time segments, respectively, in Fig. 15a–c) by 
alternating the inspired gas between pure oxygen and hypoxic gas (5% O2, 5% CO2 and 
90% N2). Vasomotion and vasodilation were clearly exhibited by the diameter oscillation 
and expansion of the vessel cross section, respectively, in response to the changes in the 
physiological state (Fig. 15a, b). To provide quantitative analysis, we estimated the vessel 
diameter by calculating the FWHM value of the blood vessel signal in each B-scan. The 
time course of the arteriolar diameter change (Fig. 15c) and the corresponding Fourier 
transform analysis (Fig. 15d) show that arteriole A1 had a significant vasomotion under 
hyperoxia, with an oscillation frequency of ~1.6 cpm, which is in good agreement with 
the observation from a previous invasive study.45 Compared with arteriole A1, venule V1 
had a much weaker vasomotion with a similar oscillation frequency (Fig. 15c, e). To 
isolate the vasodilation effect, we smoothed out the diameter oscillation due to 
vasomotion by 60-point moving averaging (Fig. 15c). The smoothed curve clearly 
suggests a significant increase of 96±3% in the arteriolar diameter under hypoxia, 
whereas the change in the venous diameter is as small as 26±5%. Our results, again, are 
in good agreement with recent work done by scanning laser ophthalmoscopy with the aid 
of fluorescent particles.46 The temporal resolution provided by OR-PAM also enabled us 
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to estimate the 10-90% full-scale response time of vasodilation to systemic hypoxia to be 
~3 minutes. 
 
4.1.4. Perspectives 
In future studies, quantification of the local metabolic rate of oxygen consumption would 
be an exciting extension.47 To this end, we need to measure the vessel diameter, blood 
oxygenation, and blood flow. The first two parameters are currently measurable with OR-
PAM, and the PAD technique has been suggested for blood flow measurement in the 
microcirculation.48 One of our future directions is to integrate PAD flow measurement 
into the OR-PAM system to assess the local metabolic rate at a microscopic level. 
Another interesting direction is to combine OR-PAM with other high-resolution 
imaging tools, such as confocal microscopy and two-photon microscopy, for multi-
modality imaging. The fruitful cellular and molecular information provided by them, 
based on scattering or fluorescence contrast, will be highly complementary. 
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Fig. 15. Vasomotion and vasodilation in response to switching the physiological state 
between systemic hyperoxia and hypoxia. (a) B-scan monitoring of the changes in the 
cross section of arteriole A1. (b) B-scan monitoring of the changes in the cross section of 
venule V1. (c) Changes in arteriolar and venous diameters in response to changes in 
physiological state (raw data were smoothed via 60-point moving averaging to isolate the 
effect of vasodilation). (d) Power spectrum of the arteriolar vasomotion tone. (e) Power 
spectrum of the venous vasomotion tone. 
33 
 
4.2 Longitudinal monitoring of microvascular wound healing in mouse ears*
4.2.1. Introduction 
 
Chronic imaging of the microcirculation in vivo permits direct visualization of long-term 
microhemodynamics, which is closely associated with disease progression,49,50 neural 
dynamics,51 and functional recovery from pathological states.52 However, existing high-
resolution microvascular imaging techniques suffer in different regards when employed 
for chronic studies. For example, invasive procedures33 and fluorescence labeling34,35 
generally disturb the normal physiology of the microcirculation, discourage longitudinal 
studies, and impede clinical translations.  
To overcome these difficulties, we have developed a bright-field PAM with 
optically diffraction-limited lateral resolution, called OR-PAM, for in vivo microvascular 
imaging down to the capillary level.41 OR-PAM is highly sensitive to the physiologically 
specific optical absorption of hemoglobin, thereby bypassing the limitations of 
invasiveness and phototoxicity. By keeping the microcirculation intact, OR-PAM is ideal 
for chronic studies. In this letter, we report on the first demonstration of using OR-PAM 
for functional chronic imaging. The healing process of a laser-induced microvascular 
lesion was monitored over a period of twelve days. Chronic OR-PAM imaging permits 
direct visualization of the morphological and functional recovery of the microcirculation 
after laser destruction. 
 
                                                 
* Reprinted with permission from S. Hu, K. Maslov and L. V. Wang, "In vivo functional chronic 
imaging of a small animal model using optical-resolution photoacoustic microscopy," Med. Phys. 
36(6), 2320-2323 (2009). 
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4.2.2. Methods 
In our OR-PAM system (Fig. 16), the animal tissue is irradiated with a short-pulsed laser 
beam generated by a wavelength-tunable laser set, consisting of an Nd:YLF pump laser 
(INNOSLAB, Edgewave) and a dye laser (CBR-D, Sirah). Wideband ultrasonic waves—
referred to as photoacoustic waves—are induced as a result of transient thermoelastic 
expansion due to the laser excitation, collected via an acoustic lens, and then detected by 
a high-frequency ultrasonic transducer (V2022 (BC), Olympus NDT). To maximize the 
sensitivity for in vivo capillary imaging, the optical illumination and the ultrasonic 
detection in our system are configured confocally by an acoustic-optical beam splitter. In 
this simple design, two right-angle prisms form a cube with a thin silicone oil layer in 
between. The glass and the silicone oil have similar optical refractive indices (1.1 in 
ratio) but very dissimilar acoustic impedances (12.7 in ratio), which makes the layer 
optically transmissive but acoustically reflective. The lateral resolution of this acoustic-
optical confocal configuration is determined by the product of the two point-spread 
functions of the optical illumination and the acoustic detection. Since acoustic resolution 
is difficult to achieve down to the capillary level due to the frequency-dependent 
ultrasonic absorption, a microscopic objective lens (RMS4X, Thorlabs) is employed to 
achieve diffraction-limited optical resolution. For chronic study, a transmission-mode 
optical microscope is integrated into our system by adding a light-emitting diode beneath 
the animal holder. Utilizing the reverse optical path of the OR-PAM illumination, the 
imaging region can be viewed under an eyepiece. This addition helps us quickly target 
the same ROI during multi-day monitoring. The detailed system description and 
performance can be found in our previously published paper.41 
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Fig. 16. Schematic of the OR-PAM system. 
 
The advantages of OR-PAM include the following: (i) Endogenous optical 
absorption contrast enables direct imaging of microvessels down to capillaries, with a 
high signal-to-noise ratio (SNR);41 (ii) Multi-wavelength measurement permits vessel-by-
vessel mapping of blood oxygenation,39, 40, 53 holding the potential for functional studies 
such as brain function mapping;54 (iii) Time-resolved ultrasonic detection provides depth 
information without depth scanning; (iv) Working in reflection mode noninvasively 
makes the technique applicable to more anatomical sites in vivo, without disturbing the 
microcirculatory function. 
 
4.2.3. Results and Discussion 
The above advantages, along with measurement consistency, permit OR-PAM to monitor 
long-term microhemodynamics. One promising application lies in the realm of laser 
microsurgery, where OR-PAM can provide fruitful structural and functional information 
about the targeted microvascular lesions, such as their morphology, precise location, and 
blood oxygenation, which will facilitate accurate diagnosis and proper treatment. More 
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importantly, OR-PAM enables noninvasive monitoring of the healing process of the 
microvascular lesions after laser microsurgery, which has been desired for a long time.55 
A mouse ear model was chosen to demonstrate this ability in vivo, because it is 
among the few anatomical sites that are readily imaged by transmission-mode optical 
microscopy, which can be used to partially validate OR-PAM. All experimental animal 
procedures were carried out in conformance with the laboratory animal protocol 
approved by the School of Medicine Animal Studies Committee of Washington 
University in St. Louis. 
One day before the beginning of the chronic study, the hair on the left ear of a 
nude mouse (Hsd:Athymic Nude-Foxn 1NU, Harlan Co., ~25 g) was gently removed with 
human hair-removing lotion (Surgi Cream, Ardell Int'l). For daily monitoring, a dose of 
87 mg/kg ketamine and 13 mg/kg xylazine was administered intraperitoneally to 
anesthetize the animal right before transferring it to a stereotaxic imaging stage. During 
the experiment, a dual-wavelength (570 nm and 578 nm) OR-PAM measurement was 
utilized to extract HbT and sO2. 570 nm is an isosbestic point, and the photoacoustic 
signal acquired at this wavelength reflects HbT. 578 nm is a local absorption peak of 
oxyhemoglobin, which helps differentiate it from deoxyhemoglobin. A detailed 
description of the method used for computing sO2 can be found in the previously 
published paper.53 Throughout each experiment, anesthesia was maintained using 
vaporized isoflurane (1.0–1.5% isoflurane with an airflow rate of 1 liter/min), and the 
body temperature of the animal was maintained at 37ºC with a temperature controlled 
heating pad. At the end of the chronic study, the animal was euthanized by an 
intraperitoneal administration of pentobarbital at a dosage of 100 mg/kg. 
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At the beginning of the chronic imaging, we selected and photographed a 1-mm-
by-1-mm region in the mouse ear under a commercial transmission-mode optical 
microscope. Then we imaged the ROI using OR-PAM (Fig. 17a), after which we 
switched the excitation source to a CW laser (output power: 150 mW; wavelength: 532 
nm) and removed the pinhole to enable the laser to create a microvascular lesion for 
study. The central part of the ROI (0.25 mm by 0.25 mm) was then scanned with the 
focused CW laser beam (diameter: ~30 µm) for ~10 min. The ROI was imaged 
immediately after the CW laser treatment (Fig. 17b) and in the subsequent twelve days 
(Fig. 17, c-1 to c-12), using both our OR-PAM system and the commercial transmission-
mode optical microscope. Our results clearly show a four-step wound healing process:56 
(i) Vessel regression and hemostasis occurred right after the laser destruction (Fig. 17b); 
(ii) Inflammation, the second phase of wound healing, was exhibited in the form of 
vasodilation 24 hours after the injury and lasted for about five days (Fig. 17, c-1 to c-5). 
Hypoxia facilitated the synthesis of the vascular endothelial growth factor to trigger 
angiogenesis (Fig. 17, b and c-1 to c-5); (iii) About three days after the wound occurred, 
the ingrowth of new capillaries started to restore the microcirculation (Fig. 17c-3), which 
was previously supplied by the damaged arteriole; (iv) After 12 days, the damaged 
arteriole-venule pair were almost completely recovered to normal status (Fig. 17c-12). 
The microvascular morphology imaged by OR-PAM is partially validated by the 
commercial transmission-mode optical microscope; however, capillary networks are only 
visible to OR-PAM. The consistency in microvascular morphology during the multi-day 
monitoring implies the robustness of our technique. 
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Fig. 17. OR-PAM monitoring of the healing process of a laser-induced microvascular 
lesion. (a) Before laser destruction. (b) Immediately after laser destruction. (c) On each of 
the subsequent 12 days. The left image in each part (a through c-12) is a photograph 
taken by a commercial transmission-mode optical microscope; the middle one is the 
front-view of the 3-D microvascular morphology acquired by OR-PAM at 570 nm; the 
right one is the MAP image overlaid by the sO2 mapping of the laser-damaged region.  
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4.2.4. Conclusion 
In this work, we demonstrated the capability of OR-PAM for functional chronic imaging 
of microhemodynamics in vivo noninvasively. However, this technique has potentially 
broader applications. In cancer research, OR-PAM can monitor tumor angiogenesis and 
evaluate tumor therapy.49 In drug development for microvascular dysfunctions, such as 
stroke, OR-PAM can trace drug functioning and evaluate drug efficacy. In the 
physiological study of angiogenesis, OR-PAM can help to understand the signal 
transduction pathway by perturbing it and detecting the difference before and after 
perturbation. In laser microsurgery, surgical lasers can be readily integrated into our OR-
PAM system to perform on-site high-precision microsurgery with pre-surgery diagnosis 
and post-surgery evaluation. In neuroscience, the noninvasive feature and fine imaging 
resolution make OR-PAM ideal for chronic studies of cortical plasticity57 as well as 
neurovascular coupling58 at the capillary level. 
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4.3 Functional transcranial imaging of adult mouse brains*
4.3.1. Introduction 
 
Advances in brain imaging facilitate the understanding of cognitive phenomena and 
neurological diseases. One of the most popular techniques is to use a single electrode or a 
microelectrode array to record neural activities directly from cortical neurons. However, 
this procedure is quite invasive, thereby limiting the number of recordings and 
discouraging chronic imaging. Alternatively, downstream hemodynamics originating 
from the brain microcirculation has been recorded to retrace the brain function.54 VSDI59 
provides direct, fast, and linear measurement of the changes in action potential of 
neurons; nevertheless, the use of dye labeling may cause phototoxicity. ISI avoids 
phototoxicity by detecting the optical scattering and absorption of biological tissues or 
the fluorescence of intrinsic chromophores;60 however, it offers a spatial resolution of 
only ~50 µm, which is not adequate for capillary imaging. TPM, possessing micrometer 
spatial resolution, has been very successful in functional brain imaging,35 but it requires 
the skull to be thinned or even removed, which impedes longitudinal studies of cortical 
plasticity and disease progression. Optical micro-angiography,61 essentially D-OCT, has 
successfully demonstrated microvascular perfusion imaging through intact mouse skulls 
by taking advantage of the intrinsic blood flow information; however, its resolution and 
sensitivity are not yet sufficient to resolve single capillaries. High-resolution brain 
imaging through intact animal skulls remains challenging for pure optical modalities 
because the optical scattering and absorption of the skull degrade the imaging resolution 
and SNR. Photoacoustic imaging, combining light and ultrasound in a single hybrid 
                                                 
* Reprinted with permission from S. Hu, K. Maslov, V. Tsytsarev, and L. V. Wang, "Functional 
transcranial brain imaging by optical-resolution photoacoustic microscopy," J. Biomed. Opt. 14, 
040503 (2009). 
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technology,47 suggests a potential solution. Using AR-PAM, Stein et al. recently 
demonstrated mouse brain imaging through both intact scalp and skull.62 This 
noninvasive feature is highly desirable for functional or chronic studies; however, with its 
current spatial resolution (lateral resolution: 70 µm; axial resolution: 54 µm), capillaries 
are not resolvable. To fill the gap, Maslov et al. developed OR-PAM capable of imaging 
single capillaries in vivo.41 The lateral resolution of OR-PAM matches the size of a single 
RBC, and its sensitivity enables single RBC detection.63 
Here, we report on the first demonstration of OR-PAM for functional brain 
microvascular imaging down to single capillaries through intact mouse skulls. The 
minimally invasive feature is favorable for chronic study of cortical plasticity. Moreover, 
since neuronal activity is widely assumed to spatially correlate most closely to the 
capillary bed response,64 improving localization of signals down to the capillary level 
will enable functional brain mapping at micrometer resolution. 
 
4.3.2. Methods 
Before functional brain imaging, a Swiss Webster mouse (Hsd:ND4, Harlan Co., 25–30 
g) was anesthetized by intraperitoneally administering a dose of 87 mg/kg ketamine and 
13 mg/kg xylazine and transferred to a stereotaxic imaging stage. The scalp of the mouse 
was surgically removed, and the exposed skull was cleaned with 0.9% sodium chloride 
irrigation solution right before imaging. Ultrasonic gel was used for ultrasound coupling 
and maintaining skull hydration. Throughout the experiment, the animal was supplied 
with breathing-grade air and maintained under anesthesia using vaporized isoflurane 
(1.0–1.5% isoflurane with an airflow rate of 1 liter/min). The body temperature of the 
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animal was maintained at 37ºC by a temperature controlled heating pad. At the end of the 
experiment protocol, the animal was euthanatized by an intraperitoneal administration of 
pentobarbital at a dosage of 100 mg/kg.  
In photoacoustic measurements of hemoglobin concentration and oxygenation, we 
assume that, in the visible spectral range, HbO2 and HbR are the dominant absorbing 
compounds in blood.65 Thus, a dual-wavelength measurement is adequate to image sO2, 
though using more wavelengths is expected to yield more accurate results.53 The two 
wavelengths chosen here are 570 nm and 578 nm, where the absorption contrast between 
blood and background brain tissues are high enough to enable satisfactory imaging 
quality.65 According to the published absorption spectra of rat hemoglobin,66 570 nm is 
an isosbestic point, at which HbO2 and HbR have the same molar extinction coefficients. 
Thus, the photoacoustic signal acquired at this wavelength reflects HbT. 578 nm is an 
HbO2-absorption-dominant wavelength, which helps differentiate the two types of 
hemoglobin. Since blood oxygenation is highly correlated with local metabolism, the sO2 
value is generally time-variant. To minimize measurement error due to the possible 
temporal fluctuation in blood oxygenation, we implemented a wavelength auto-tuning 
program to control the dye laser, and imaged the same B-scan for each of the 
wavelengths before moving to the next B-scan. The ROI was scanned with a step size of 
2.5 µm. The dual-wavelength measurement took approximately 20 minutes, which was 
mostly limited by the wavelength tuning speed of the dye laser. 
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4.3.3. Results and Discussion 
Figures 18a and 18b are MAP images of the mouse brain microvasculature under 
systemic normoxia at the optical wavelengths of 570 nm and 578 nm, respectively. Since 
570 nm is an isosbestic point, Fig. 18a maps the HbT, regardless of the blood 
oxygenation. Microvessels labeled with CL in Fig. 18a appear to be single capillaries 
with diameters of 5–10 µm. At the conclusion of the dual-wavelength measurement, the 
concentrations of HbR and HbO2, as well as the sO2 values, were calculated based on the 
model described in previously published work.53, 65 As shown in Fig. 18c, different sO2 
levels are visualized with pseudocolors ranging from blue to red, while the HbT 
measured at the isosbestic point (570 nm) is represented by pixel brightness. According 
to known physiology, the red vessels (sO2 values greater than 90%) are believed to be 
arterioles, whereas the green ones (sO2 values as low as 60–70%) are most likely to be 
venules. However, in the microcirculation, there is no clear cutoff in sO2 value between 
arterioles and venules.67 The blood oxygenation is closely associated with the 
microvascular branching order67 and the local metabolic activity of the tissue.68 To 
demonstrate the oxygen gradients in the brain microcirculation, we selectively analyzed a 
post-capillary venular tree (Fig. 18d) and a pre-capillary arteriolar tree (Fig. 18e) 
highlighted in Fig. 18c by the blue and red dashed boxes, respectively. The vessel 
diameters and the corresponding sO2 values in different branching orders are listed in 
Table 2. A negative correlation between the branching order and its mean sO2 value is 
observed in both the arteriolar and venular trees with a linear regression analysis 
(arteriolar tree: R2 = 0.98, p = 0.01; venular tree: R2 = 0.75, p = 0.14), as shown in Fig. 19. 
Our results suggest that: (i) the blood oxygenation level is higher in the arteriolar tree 
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than in the venular tree; (ii) capillaries are not the only oxygen exchange site in the 
microcirculation, because the sO2 decreases significantly with vascular branching in the 
pre-capillary arteriolar tree (~12% from order 1 to 4); and (iii) a diffusional shunt is 
present between arterioles and venules to elevate the oxygen level in “large” venules, 
because the sO2 increases noticeably with blood confluence in the post-capillary venular 
tree (~9% from order 1 to 4). Our observation is in agreement with the published work.67-
69  
 
Fig. 18. In vivo functional OR-PAM imaging of mouse brain microvasculature through 
an intact skull. (a) MAP image acquired at 570 nm;(b) MAP image acquired at 578 nm; 
(c) vessel-by-vessel sO2 mapping; (d) a venular tree with branching orders [boxed by 
blue dashed lines in (c)]; (e) an arteriolar tree with branching orders [boxed by red dashed 
lines in (c)]. The calculated sO2 values are shown in the color bar. PA: photoacoustic 
signal amplitude. The scale bar applies to (a–c). 
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Fig. 19. The sO2 value versus the vascular branching order in a pre-capillary arteriolar 
tree and a post-capillary venular tree. The square and round markers represent the mean 
sO2 values in each branching order, and the error bars stand for the standard deviations of 
the mean sO2 values. 
 
Table 2(a). The vessel diameters and the sO2 values in different branching orders in a 
venular tree. Values are in mean ± standard deviation format. 
Branching 
 
1 2 3 4 
Vessel ID V1 V2(a) V2(b) V3(a) V3(b) V3(c) V3(d) V4(a) V4(b) 
Vessel 
 
 
57±2 48±5 42±3 35±2 30±2 41±2 24±3 20±2 19±3 
sO2 (%) 83±3 83±3 85±2 86±3 83±3 78±2 75±4 74±5 76±4 
 
Table 2(b). The vessel diameters and the sO2 values in different branching orders in an 
arteriolar tree. Values are in mean ± standard deviation format. 
Branching 
 
1 2 3 4 
Vessel ID A1(a) A1(b) A2(a) A2(b) A3(a) A3(b) A3(c) A3(d) A4(a) A4(b) 
Vessel 
 
 
59±4 48±3 43±4 52±2 44±4 32±2 51±2 42±4 23±3 24±2 
sO2 (%) 93±2 93±2 91±3 91±3 89±2 88±4 87±3 79±3 85±2 81±3 
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According to a previous study,70 the wavelength-dependent optical attenuation 
due to the intact skull affects the measurement accuracy. Here, this wavelength 
dependence was estimated by measuring the photoacoustic signals of a black 
polyethylene film attached beneath the skull of a freshly sacrificed mouse of the same 
type at the two operating wavelengths, respectively. The mouse skull was submerged in 
0.9% sodium chloride irrigation solution to keep hydration. Since the black polyethylene 
film can be considered as a neutral absorber in the visible spectral range, the wavelength 
dependence in the photoacoustic signals is expected to be predominantly from the mouse 
skull. If we consider the skull to be homogeneous within the ROI,65 such dependence can 
be simply compensated for by applying different calibration factors to the measured 
photoacoustic signals at different optical wavelengths. However, the wavelength-
dependent optical scattering and absorption of brain tissues are difficult to compensate 
for due to heterogeneous tissue structure and composition.71 
 
4.3.4. Conclusion 
In summary, OR-PAM has been applied to mouse brain imaging through intact skulls 
with capillary-level spatial resolution. Functional information of HbT and sO2 within 
single microvessels was imaged simultaneously using a dual-wavelength measurement. 
The ability to extract brain oxygen saturation information on a single capillary basis with 
minimal invasiveness makes OR-PAM a potential tool for high-resolution functional 
brain mapping, quantitative analysis of brain energy metabolism, and chronic studies of 
cortical plasticity and neurological diseases. It is worth noting that the maximum imaging 
depth of OR-PAM, estimated from the surface of the intact skull, is 500–600 µm when 
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the system is operated at the Q-band of the hemoglobin absorption spectrum (optical 
wavelength: ~560 nm). This penetration is slightly less than the typical imaging depth of 
TPM (600–800 µm) through a skull window with NIR excitation,72 where no bone is in 
the optical path. NIR light sustains less brain tissue absorption and scattering than visible 
light. However, owing to the quadratic intensity-dependence in two-photon generation 
and linear dependence in OR-PAM, the light scattering and absorption within the intact 
skull as well as the surface scattering at the skull-brain interface decreases the 
fluorescence signal in TPM much faster than the photoacoustic signal in OR-PAM. As a 
result, TPM has not demonstrated transcranial imaging. By utilizing NIR operation and 
compromising the lateral resolution, D-OCT can extend the imaging depth to ~1.5 mm.61 
To enhance the penetration of OR-PAM, system SNR or imaging contrast needs to be 
further improved. 
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4.4 Label-free photoacoustic angiography of mouse eyes*
4.4.1. Introduction 
 
Visual impairment is highly prevalent worldwide. Ten percent of the U.S. adult 
population has experienced vision problems,73 many of which are manifest in the ocular 
circulation.74 Fluorescence angiography is very successful in the diagnosis of ocular 
vascular diseases and has been well accepted as the gold standard for ocular circulation 
imaging. However, an inherent limitation of fluorescence angiography is the required 
injection of contrast agents (fluorescein or indocyanine green) that can cause pain and 
complications such as emesis, anaphylactic reactions, or even death.75 Moreover, the 
angiographic agents may fail to perfuse if there is conspicuous vascular leakage. Thus, 
the development of label-free imaging techniques to avoid these problems is warranted. 
Our previous work on photoacoustic tomography, an emerging hybrid technique 
capable of detecting optical absorption ultrasonically, has demonstrated its unique 
advantage of utilizing endogenous hemoglobin contrast for subcutaneous and cortical 
vascular imaging in living animals as well as in humans.39, 58 With recent advances in 
optical illumination and ultrasonic detection mechanisms,41 we have successfully 
extended the application of this technique to ophthalmology. Here, we report OR-PAM 
for in vivo label-free functional imaging of the ocular microcirculation. 
 
4.4.2. Methods 
To achieve spectroscopic measurements, our OR-PAM system (Fig. 20) employs a 
wavelength-tunable laser system consisting of a Nd:YLF pump laser (INNOSLAB, 
                                                 
*  Reprinted with permission from S. Hu, B. Rao, K. Maslov, and L. V. Wang, “Label-free 
photoacoustic ophthalmic angiography,” Opt. Lett. 35 (1), 1–3 (2010). 
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Edgewave) and a dye laser (CBR-D, Sirah). The laser beam is attenuated by a neutral 
density filter (NDC-100C-2, Thorlabs) before being spatially filtered through a 25-µm 
pinhole (P25C, Thorlabs), and then is focused by a microscope objective (RMS4X, 
Thorlabs) to achieve micrometer lateral resolution. An optical beam splitter, in 
combination with a photodiode (SM05PD1A, Thorlabs), is inserted between the pinhole 
and the microscope objective to monitor laser intensity fluctuation. A homemade 
acoustic-optical beam splitter, consisting of two right-angle prisms (NT32-545, Edmund 
Optics) and a 100-µm thick layer of silicone oil (1000cSt, Clearco Products), is placed 
under the objective lens to separate optical illumination and acoustic detection.41 A 75-
MHz ultrasonic transducer (V2022 BC, Olympus NDT) is attached to the vertical side of 
the bottom prism. An acoustic lens (NA: 0.46; radius of curvature: 5.2 mm) is attached to 
the bottom of the splitter and immersed in the water tank to collect photoacoustic signals. 
An imaging window in the bottom of the water tank is sealed with an ultrasonically and 
optically transparent polyethylene membrane. Typically, before imaging, an adult Swiss 
Webster mouse (Hsd:ND4, Harlan Co., 25–30 g) was anesthetized and transferred to a 
homemade stereotaxic imaging stage. Lubricating drops (Butler AHS) were gently 
administered to both eyes, and then ultrasonic gel was evenly applied between the 
imaging window and the eye for ultrasound coupling and eye hydration. The water tank 
had a low-pressure contact with the cornea to avoid possible disturbance to the intrinsic 
ocular circulation. Anesthesia was maintained throughout the experiments by an 
isoflurane machine (1.0–1.5% vaporized isoflurane with an airflow rate of 1 L/min). The 
body temperature of the animal was maintained at 37 ºC with a temperature controlled 
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heating pad. At the end of the experiments, the animals were euthanized by an 
intraperitoneal administration of pentobarbital at a dosage of 100 mg/kg. 
 
Fig. 20. Schematic of the photoacoustic ophthalmic angiography system. The inset 
photograph shows the animal positioning. λ: wavelength; AO: acoustic-optical; ND: 
neutral density. 
 
4.4.3. Results and Discussion 
Compared with conventional fluorescence angiography, OR-PAM has multiple 
advantages. First, hemoglobin absorption provides endogenous and functional imaging 
contrast. In OR-PAM, a nanosecond-pulsed laser beam is absorbed by hemoglobin 
molecules circulating in the ocular microvasculature. The resulting transient 
thermoelastic expansion induces wideband ultrasonic waves, which are detected by a 
high-frequency ultrasonic transducer to form a projection or volumetric angiogram (Fig. 
21a). Since hemoglobin is the predominant light absorber in the intrinsic microcirculation, 
blood vessels detected by OR-PAM must contain RBC, the carrier of hemoglobin. This 
characteristic guarantees that OR-PAM images only RBC-perfused capillaries, the 
functional subset of capillaries responsible for supplying oxygen to the eye.  
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A second advantage is that tight optical focusing and the high nonradiative 
quantum yield of hemoglobin enable single-RBC resolution and sensitivity. The 5-µm 
resolution in our current design matches the average size of single RBCs. Moreover, 
hemoglobin is a non-fluorescent molecule, and thus almost all the absorbed photon 
energy is converted to heating, which elicits photoacoustic emission. OR-PAM’s 
micrometer spatial resolution enables visualizing individual RBCs traveling along iris 
capillaries (Fig. 21b). The Gaussian fit of the cross-sectional photoacoustic signal profile 
(Fig. 21c) of a chosen particle observed by OR-PAM (crossed by the red dashed line in 
Fig. 21b) has a FWHM of ~6 µm. The size and high contrast-to-noise ratio (~20 dB) 
suggest that these particles (the yellow arrows in Fig. 21b) are single RBC disks imaged 
sideways. The high detection sensitivity also permits the use of a laser exposure level 
well within the ANSI safety standards (expanded upon later).  
 
Fig. 21. Label-free photoacoustic ophthalmic angiography of the iris microvasculature of 
a living adult Swiss Webster mouse. (a) The MAP image acquired at 570 nm. (b) A 
close-up of the boxed area in panel a. The yellow arrows indicate individual RBCs in iris 
capillaries. (c) The profile of an RBC crossed by the red dashed line in panel b. LIC: 
lesser iris circle. PA: photoacoustic signal. 
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Third, endogenous contrast combined with low-level exposure enables repetitive 
imaging or chronic monitoring, which is highly desirable for treatment evaluation and 
drug development. As a simple demonstration, we re-imaged the same ROI shown in Fig. 
21a. With the focal plane lowered towards the posterior segment, the peripheral vascular 
structures—the CP, RCB, and MIC that bifurcates into multiple RIA—are better 
visualized in Fig. 22, though the LIC are slightly blurred. Compared with Fig. 21a, Fig. 
22 shows essentially no change in the general microvascular morphology.  
As a fourth advantage, spectroscopic measurements offer functional 
characterization of blood oxygenation. Capitalizing on the distinct difference in the 
absorption spectra of HbO2 and HbR, we used two excitation wavelengths (570 and 578 
nm) to estimate the concentrations of HbO2 and HbR, thereby mapping the sO2 on a 
single-vessel basis (the dashed-line box in Fig. 22). Blood oxygenation levels are 
pseudocolored from blue to red in an ascending order. From the sO2 mapping, we can 
clearly identify the RIAs, and we can also observe the transition in blood oxygenation 
from arteries to veins.  
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Fig. 22. Label-free photoacoustic ophthalmic angiography of sO2 in the iris 
microvasculature of a living adult Swiss Webster mouse. The imaged region is the same 
as that shown in Fig. 21a, but with a focal plane closer to the posterior segment to better 
visualize the peripheral vascular structures. A dual-wavelength (570 and 578 nm) sO2 
measurement was performed on the boxed region of interest. A vessel-by-vessel sO2 
mapping was generated and overlaid on the maximum amplitude projection image 
acquired at 570 nm. CP: ciliary process; MIC: major iris circle; RCB: recurrent choroidal 
branch; RIA: radial iris artery. 
 
For potential clinical applications, the MPE that OR-PAM can apply is subject to 
the ANSI safety standards for the eye.76 Since the PRF of our OR-PAM laser is less than 
the critical frequency (55 kHz for wavelengths between 0.4 to 1.05 µm), three ANSI rules 
need to be tested. The experimental parameters used for the following calculation are 
listed in Table 3. 
Rule 1. Single Pulse Limit. The MPE for a single laser pulse is  
 [ ]247SP J1033.1100.5MPE cmCE −− ×=×= ,                                 (1) 
where ( ) 267minmax2 == αααEC  is the extended source correction factor. Here, αmax = 
100 mrad is the apparent angle subtended by a source above which the thermal hazard is 
proportional to the radiance of the source, and αmin = 1.5 mrad is the apparent angle 
subtended by a source above which extended source MPEs apply. 
Rule 2. Average Power Limit. First, consider one B-scan. During each B-scan, the 
OR-PAM laser sends a pulse train containing 1600 pulses with a PRF of 600 Hz. Since 
the B-scan exposure time (~2.7 s) is longer than 0.7 s and the wavelength is between 400 
54 
 
and 600 nm, dual limits due to both photochemical and thermal effects apply here. For 
photochemical effects, the MPE for the B-scan pulse train is 
( ) [ ]262Bscan J790104C100)(MPE cmcalphotochemi B =××= −απ ,            (2) 
where ( ) 25110 45002.0 == −λBC  is the wavelength correction factor, and α = 200 mrad is 
the angular subtense. For thermal effects, the MPE for the B-scan pulse train is 
[ ]2375.0Bscan J01.1108.1)(MPE cmTCthermal BscanE =×= − ,                  (3) 
where TBscan = 2.7 s is the exposure duration of each B-scan as listed in Table 3. Thus, the 
MPE/pulse for the B-scan pulse train is 
[ ]24Bscan J103.6)(MPE cmnthermal Bscan −×= ,                             (4) 
where nBscan = 1600 is the number of pulses in each B-scan. Second, consider the total 2-
hour laser exposure. For photochemical effects, the MPE for the total exposure duration 
is the same as that for each B-scan, as calculated in Eq. (2). For thermal effects, the MPE 
for the total exposure duration is 
[ ]2max325.02Total J1093108.1)(MPE cmTTCthermal E =⋅×= −− ,            (5) 
where T2 = 100 s is the exposure duration beyond which the thermal MPE for an 
extended source is constant in terms of irradiance, and Tmax = 7200 s is the duration of a 
complete exposure. Thus, the MPE/pulse for the total 2-hour laser exposure is 
[ ]24Total J101.3)(MPE cmncalphotochemi Total −×= ,              (6) 
where nTotal = 2.56×106 is the number of pulses in the total 2-hour exposure. 
Rule 3. Repetitive Pulse Limit. The MPE is 
[ ]26SP25.0RP J103.3MPEMPE cmnTotal −− ×== .                      (7) 
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Rule 3 is the most conservative of the three. Therefore, the overall MPE for each 
pulse is 3.3×10-6 J/cm2. If the pupil diameter D is 7 mm,76 the maximum permissible 
single laser pulse energy in our OR-PAM system is 
 ( ) [ ],J3.12DMPE 2RP µπ =××                    (8) 
which is ~30 times greater than our experimentally used laser pulse energy of ~40 nJ. 
 
Table 3. Experimental parameters. 
λ (nm) PRF (Hz) t (s) TBscan (s) Tmax (s) α (mrad) 
570 and 578* 600** 7×10-9 2.7** 7200** 200*** 
 
λ: wavelength; PRF: pulse repetition frequency; t: duration of a single pulse; TBscan: 
exposure duration of each B-scan; Tmax: duration of a complete exposure; α: angular 
subtense. 
 
*Because 570 and 578 nm are close to each other and show minimal differences in terms 
of the safety limits, we use 570 nm throughout the calculation. 
 
**In the experiments shown in Figs. 21a and 22, the imaged region of interest is 4 mm by 
4 mm, with a scanning step size of 2.5 µm. Unidirectional B-scan is utilized to avoid the 
effect due to the backlash of the mechanical scanner. Each forward B-scan takes ~2.7 s, 
and the scanner reposition takes another ~1.8 s. The total image acquisition time is ~2 hr 
(7200 s), which is limited by the mechanical scanning speed. 
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***The angular subtense is estimated by the NA of the microscope objective, which is 
0.1 in our current system. 
 
4.4.4. Conclusion 
Thus, we conclude that OR-PAM eliminates the need for injected contrast agents, offers 
significant promise for diagnosis and monitoring of ocular diseases, and poses essentially 
no radiation hazards. For clinical applicability, the next step is to improve the imaging 
speed of the system, through methods such as optical scanning.77 
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III. OR-PAM IN VASCULAR BIOLOGY 
1. HIF-mediated multistage neovascularization with stage-specific sensitivity to 
VEGFR inhibitors*
1.1 Introduction 
 
Neovascularization is a process whereby new vessels are created and existing ones 
remodeled to supply growing or ischemic tissues with oxygen and nutrients. While 
numerous studies have been performed in preclinical tumor or ischemia models, 
determination of the mechanisms of angiogenesis and neovascularization regulation in 
the absence of disease could provide insight into endothelial cell signaling and stromal 
cell trafficking otherwise obscured by a microenvironment altered by illness.  
Neovascularization is an adult developmental program that unfolds over time, 
induced by a collection of angiogenic factors. However, preclinical studies of 
neovascularization have focused on one or a few time points in what is a continuous 
process, or have used vectors transiently expressing elevated levels of angiogenic 
factors.78 Adult neovascularization and stromal remodeling in the absence of disease were 
studied using Tet-inducible VEGF.79 However, because of the inaccessibility of organs 
targeted for VEGF gain of function, liver and heart, neovascular development was not 
studied using day-to-day analysis following transgene activation. Moreover, these organs 
possessed a tissue cellular organization that made spatial analysis between transgene 
broadcasting and receiving vascular cells challenging. Another strategy for conditional 
adult neovascular induction was cell autonomous regulation, within the endothelial cell 
                                                 
* Reprinted with permission from Sunday Oladipupo†, Song Hu†, Andrea C. Santeford, Junjie 
Yao, Joanna Kovalski, Ralph V. Shohet, Konstantin Maslov, Lihong V. Wang, and Jeffrey M. 
Arbeit, “Conditional HIF-1 induction produces multistage neovascularization with stage-specific 
sensitivity to VEGFR inhibitors and myeloid cell independence,” Blood, (Under revision). † 
Authors contributed equally to this work. 
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itself. There, high-level transgenic overexpression of constitutive myristoylated AKT 
produced marked alterations of microvessel structure and stromal edema; however, the 
kinetics of neovascular development was not investigated.80  
Neovascularization is also ideally suited to serial imaging. Elegant studies 
delineated alterations of both the microvasculature and the microenvironment using 
optical microscopy techniques, such as single- or multi-photon fluorescence microscopy 
and D-OCT.50 However, challenges with such pure optical techniques included the 
requirement for repeated fluorescent dye injections, the need for tissue window 
construction, or the necessity for blood flow.81, 82 
In most instances, neovascularization in disease is coordinated by induction of the 
HIF family, primarily HIF-1 and HIF-2.83 These transcription factors are heterodimers of 
an oxygen-labile HIF-1 or -2alpha (α) subunit, each paired with the same stable HIF-beta 
(β) subunit. Oxygen instability is mediated by prolyl hydroxylase catalyzed 
hydroxylation of proline residues within the “oxygen-dependent degradation domain”, 
ODD.84 Non-hypoxic HIF-α induction is produced by enhanced HIF mRNA translation 
controlled by PI3 kinase-mTOR pathway activation.85 HIF-1 and -2 induce expression of 
multiple angiogenic factors.86 HIFs signal angiogenesis via paracrine,18 autocrine,87 and 
endocrine mechanisms.88 HIF-1 and -2α protein overexpression has been documented in 
human ischemic tissues and organs, high-grade premalignant lesions, and cancers.83, 85 
HIF-1α expression levels are also prognostic in clinical malignancies.85 Previously, we 
reported that germline transgenic expression of a HIF-1α∆ODD mutant in skin produced 
hypervascularity with microvessels of normal morphology. However, the vasculature in 
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that model was quiescent lacking endothelial proliferation, angiogenesis, or 
microvascular network growth over time.18  
Here we deployed a conditional expression strategy to create a disease-free model 
of HIF-1 induction in adult epithelium. We targeted a DOX-regulated, oxygen-insensitive 
HIF-1α transgene to mouse skin (TetON-HIF-1 mice). HIF-1 activation produced three-
stages of neovascularization: development, maintenance, and transgene-dependent 
regression. Surprisingly endothelial proliferation was cell autonomously downregulated 
by a DNA damage checkpoint despite persistent VEGFR2 activation. Moreover, myeloid 
cells recruited to the skin stroma neither contributed to neovascularization nor to VEGF 
inhibitor resistance. PAM longitudinally imaged and determined microcirculatory 
dynamics during neovascular network development, transgene-dependent regression, and 
stage-specific angiogenic inhibitor responsiveness. The preclinical TetON-HIF-1 model 
and L-PAM technology are promising tools for studying angiogenesis and the 
microenvironment as they are altered during neovascularization. 
 
1.2 Results 
1.2.1. Model development, transgene, and target gene expression kinetics  
Basal keratinocytes were chosen as targets for conditional HIF-1 induction in TetON-
HIF-1 DTG mice because they are epithelial cells distributed along the epidermal 
basement membrane, ideally positioned for paracrine signaling to the stroma.89 Ear skin 
was chosen for detailed investigation, because of its paucity of fur and its frequent use in 
several transgenic and adenoviral-mediated angiogenesis studies.18, 78, 90, 91 However, 
TetOn-HIF-1 truncal skin displayed similar stromal alterations (data not shown). To 
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control for purported antiangiogenic and protease inhibitor activities of DOX,92 NTG 
mice were fed DOX for intervals matching TetON-HIF-1 mice. As DOX day 0 (d0) 
TetON-HIF1 and NTG mice were phenotypically, microscopically, and molecularly 
similar, either genotype was used as a control in appropriate experiments. Transgene 
mRNA was upregulated within 24 hr of DOX provision and remained elevated during 
continuous induction (Fig. 23A). DOX-regulated transgene expression was slightly leaky 
at the mRNA level (data not shown), but tight at the protein level (Fig. 23B). The 
mRNAs of two canonical HIF-1 target genes, GLUT1 and carbonic CAIX, were rapidly 
induced and persistently elevated during continuous DOX exposure (Fig. 23A). 
 
Fig. 23. DOX HIF-1αP402A/P564A/N803A transgene induction and target gene upregulation. 
(A) Real-time RT-PCR analysis of rapid and sustained elevations of transgene and 
“canonical” HIF-1 target gene mRNA’s represented by GLUT1 and CAIX in TetON-
HIF-1 transgenic (denoted as “DTG” double transgenic) compared to NTG mice during 
continuous DOX induction. Prior analysis demonstrated no difference between NTG and 
DOX d0 TetON-HIF-1 controls. (B) Transgene protein expression from Western blots of 
ear nuclear extracts on DOX d14 in DTG, single TRE-HIF-1αP402A/P464A/N803A transgenic 
mice (NTGTG), or NTG controls. Each dot in scatter plots represents one mouse. 
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Horizontal bars represent the mean. Gene expression measurements for HIF-1α, GLUT1 
and CAIX were from the same samples. DTG data at each DOX day were compared with 
NTG or TetON-HIF-1 d0 data (data not shown), using unpaired Student’s t-test 
(**P<0.01 and *** P<0.001). 
 
1.2.2. Epithelial HIF-1 activation produces angiogenesis and a patterned 
microvasculature 
DOX-induced TetON-HIF-1 mice developed skin redness and vascular prominence, 
noticeable on d3 of continuous DOX induction and peaking by DOX d14 (Fig. 24A). 
Histopathology was confined to the stroma, which displayed an increase in microvessels 
and mononuclear cells (data not shown). Vascular density increased four-fold by d14 (Fig. 
24B, D) with microvessels decorating the undersurface of the interfollicular epidermis 
and the hair follicles (Fig. 24B). Whole mounts revealed development of a patterned 
neovasculature surrounding each hair follicle (Fig. 24C). This microvessel organization 
was produced by keratin-5 rtTA induction in hair follicle outer root sheath cells and 
sebaceous glands93 (Fig. S1A). Endothelial tip cells with filopodia extending toward the 
transgene expressing epidermal cells were also detectable on d3 of continuous DOX 
induction (Fig. S1B). 
 
1.2.3. Noninvasive determination of microhemodynamics during 
neovascularization  
Label-free noninvasive L-PAM (Fig. S2) monitoring of individual DOX-induced TetON-
HIF-1 transgenic mice from d0–60 demonstrated a progressive four-fold elevation in total 
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microvessel volume, concordant with immunofluorescent vessel density analysis (Fig. 
24B, D, and Fig. S2E). L-PAM also resolved the perifollicular neovascular capillaries, as 
well as their afferent and efferent vessels (Fig. 24C, light blue and yellow arrowheads in 
the red boxed L-PAM close-up). 2-D projection images (Fig. 24B) further revealed 
extensive dilatation, tortuosity, and remodeling of large-caliber arteriovenous vessels 
during continuous epithelial HIF-1 activation (Fig. S2D, F–G). Using L-PAM’s 
resolution and depth-sectioning capability, we determined the kinetics of capillary versus 
arteriovenous volume changes for extended intervals following HIF-1 induction, based 
on vessel caliber and 3-D morphology41, 94 (Fig. S2D–E). Capillary volume tripled on d3, 
then abruptly increased to a 15-fold elevation by d14 predominantly due to capillary 
genesis. Capillary volume remained at the same elevated level from d14–60. In contrast, 
arteriovenous vessel volume expansion was more gradual, modest, and persistent, 
reaching a 3- to 4-fold elevation by d60. Arteries and veins also evidenced increased 
tortuosity, defined as the ratio of the vessel length to the linear distance between two 
adjacent bifurcation points, between d14–60 (Fig. 24B, Fig. S2D, F, G). The volume 
increase for the entire neovasculature was similar to that of the arteriovenous network, 
which comprised the majority of total vessel volume (Fig. S2E). NTG mice treated with 
DOX from d0–60 evidenced no change in vessel density or volume either by L-PAM or 
immunofluorescence (Fig. S2C, E, F). Collectively, these L-PAM and vascular density 
data demonstrate that TetON-HIF-1 neovascularization comprises two stages following 
DOX-HIF-1 induction: a development stage consisting of angiogenesis, microvessel 
growth, and organization into perifollicular microvascular clusters, and a maintenance 
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stage wherein the capillary network is metastable (see below) and the arteriovenous 
vessels continuously remodeled. 
 
Fig. 24. Multistage angiogenesis, microvascular network patterning, and serial 
noninvasive imaging of neovascularization by L-PAM in TetON-HIF-1α transgenic mice. 
(A) Neovascular phenotype of a TetON-HIF-1 transgenic mouse with skin redness and 
vascular prominence developing 14 days following continuous DOX provision. (B) 
Comparative determination of TetON-HIF-1 neovascularization using 
immunofluorescent thin section microvessel markers, MECA32/vWF, with L-PAM. L-
PAM was performed in the same transgenic mouse serially imaged for 60 days [red box 
indicates the microvascular domain magnified in (C)]. (C) Ear whole mount images of 
FITC-Lysopersicon esculentum perfused TetON-HIF-1 mice over time (red arrowheads 
in d14 and d30 images indicate neocapillaries surrounding each rtTA/HIF-1 expressing 
hair follicle). The L-PAM image insert (in gray scale) and the d30 high power whole 
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mount micrograph show similar conformation of the perifollicular neocapillaries. The 
light blue arrowhead points to the afferent vessel, while the yellow arrowhead points to 
the efferent vessel. (D) Microvascular density as determined by vessel counting of 
MECA32/vWF double immunofluorescence tissue sections ex vivo, and microvessel 
volume derived from in vivo L-PAM of serially imaged individual TetON-HIF-1 mice 
(n=1–4 for indicated time points) normalized to NTG controls, demonstrating the same 
trend of rapid elevation and then plateau by d14. Data for each DOX day were compared 
with NTG or TetON-HIF-1 d0 data (data not shown), using unpaired Student’s t-test 
(*P<0.05, **P<0.01 and *** P<0.001 Bars: (B), 200 µm; (C), 100 µm. 
 
1.2.4. Dynamics of microvascular regression following transgene withdrawal, 
independent of endothelial pericyte coverage  
Temporal HIF-1 control allowed us to determine mechanisms of microvascular stability 
or regression following transgene and consequent angiogenic factor withdrawal. HIF-1 
was DOX- induced for 14, 30, or 60 days to produce a neovasculature, then withdrawn 
for increasing intervals ranging from 1–60 days (Fig. 25A–B). Microvessel persistence 
was exquisitely dependent on continuous epithelial HIF-1 function, with a two-fold 
overall reduction of vascular density upon DOX withdrawal (Fig. 25B). Whole mounts 
demonstrated a marked dropout of perifollicular microvessels as early as post-withdrawal 
d3, with persistence of neovessels that developed at the greatest distance from the 
transgene expressing hair follicles (Fig. S3A). Overall there was a permanent 30% 
microvessel increment compared to controls (Fig. 25A, B, and Fig. S3A). Longer periods 
of transgene expression, either for 30 or 60 days, did not produce further increases in 
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permanent neovessels (Fig. 25B). Endothelial and perivascular cell apoptosis was 
activated as early as d1, peaked on d3, and fell to near baseline levels by withdrawal d14 
(Fig. 25C). Apoptotic endothelial cells were most frequently detected immediately 
adjacent to the formerly transgene-expressing hair follicle basal cells (Fig. 25C, white 
arrowheads). These data suggested that these microvessels were “addicted” to high 
angiogenic factor levels, whereas microvessels developing at a distance from the 
transgene expressing hair follicles became angiogenic growth factor independent. DOX 
withdrawal experiments defined the third stage of TetON-HIF-1 neovascularization, HIF-
1-dependent microvessel regression. 
The high resolution and large FOV of L-PAM functionally delineated the entire 
process of neovascular regression (Fig. 25A, middle column). Magnified images showed 
the preexisting arteriolar-venular feeder loop on d0, and perifollicular neovessel 
establishment by d14 with feeder loop dilatation (Fig. 25A, right column). On withdrawal 
d3, these neovessels were intact, though of markedly decreased luminal diameter, as 
individual RBCs with intervening gaps, likely plasma, were delineated by L-PAM (Fig. 
25A, purple arrowhead, each white dot represents a single RBC). By withdrawal d14, 
most of these neovessels regressed with persistence of the peripheral capillary ring. 
As pericytes can convey microvascular stability, we predicted that they would be 
sporadically or loosely associated with TetON-HIF-1 capillary endothelial cells, given 
the marked microvessel transgene dependence (see next section), and the multiple 
potential angiogenic HIF-1 target genes.95 Moreover, we also predicted that endothelial 
pericyte coverage would be lacking or sparse on development stage microvessels, as 
previously reported in studies of postnatal retinal vascular development.96 However, 
66 
 
neither prediction was correct in TetON-HIF-1 mice. Desmin positive pericytes tightly 
covered each microvessel throughout neovascular development and maintenance, from 
d0 to d30, including vessels closest to high level multi-angiogenic growth factor 
expression, the perifollicular and subepidermal microvasculature (Fig. 25D, E, and Fig. 
S3B). We also delineated dynamic alterations in pericyte marker expression. While 
desmin was constitutively present in perivascular cells, PDGFRβ and NG2 expression 
were undetectable during DOX d1–3, then upregulated by d14, but again undetectable by 
DOX d30 (Fig. S3B). αSMA expression was restricted to large caliber stromal arteries 
and veins (Fig. 25D). These data reveal that the type of pericyte marker expressed on 
neovessels is temporally regulated, and in addition, controlled by the microvessel tissue 
and biologically context.97 
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Fig. 25. Pericyte marker expression and microvessel stability following HIF-1 
withdrawal. (A) Representative lectin-perfused whole mounts (left column) and L-PAM 
images (middle and right columns) during HIF-1 induction (d0, d14) followed by DOX 
withdrawal 14/3 (14d ON/ 3d OFF), 14/14 (14d ON/ 14d OFF). Neocapillaries that 
developed farthest from the hair follicles remain after withdrawal accounting for a 
persistent 30% increase in vascularity compared to DOX d0 or NTG controls. L-PAM 
images are obtained from the same TetON-HIF1 transgenic mouse imaged over 28 days. 
L-PAM detects development of perifollicular neocapillary unit (green arrowhead) with its 
feeder arteriole (red arrowhead) and draining venule (blue arrowhead), capillary luminal 
diminution with “single file” RBCs on withdrawal d3 (purple arrowhead), and involution 
with persistence of peripheral microdomain capillaries by withdrawal d14 (right column). 
(B) Quantification of microvessel density (MECA32 immunofluorescence, in black) and 
volume (L-PAM, in purple) in TetON-HIF-1 on DOX d14, d30, and d60, and following 
increasing intervals of DOX activation followed by commensurate periods of withdrawal, 
14/14, 14/28, 30/30, and 60/60 (n=1–5). (C) Induction of perifollicular endothelial cell 
apoptosis (dual positive, MECA32+/caspase-3+ cells, arrowheads right panel) following 
one day of DOX withdrawal (upper panel), and quantification of apoptotic indices over 
time (bottom panel). (D) Thin section dual endothelial (MECA32) and pericyte marker 
immunofluorescence demonstrates coverage of TetON-HIF-1 DOX d14 induced 
microvessels by desmin, PDGFRβ, and NG2. αSMA is expressed only in vascular 
supporting cells of deep stromal large vessels. (E) Confocal immunofluorescence 
demonstrates extensive and intimate microvessel coverage by desmin (+) pericytes at all 
time points following DOX induction (arrowheads delineate endothelial tip cells also 
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shown in detail in Fig. S1B). TetON-HIF-1 data at each DOX day were compared with 
NTG or TetON-HIF-1 d0 data (data not shown), using unpaired Student’s t-test (*P<0.05 
and *** P<0.001). Bars: (A) and (D), 100 µm; (C), 50 µm; (E), 20 µm. 
 
1.2.5. Epithelial HIF-1 activation upregulates angiogenic target genes and produces 
persistent VEGFR2 signaling discordant with endothelial proliferative 
quiescence 
To probe the molecular underpinnings of epithelial HIF-1-mediated neovascularization 
and regression, we determined DOX-induced alterations of angiogenic HIF-1 target 
genes (Fig. S4A–C). VEGF, PlGF, PDGF-B, and iNOS mRNAs rapidly increased, then 
plateaued or decreased. ADM, SDF1α, and angiopoietin-2 slowly rose, whereas 
thrombospondin-1, an angiogenesis inhibitor and a target of suppression by hypoxia,98 
progressively decreased. VEGF and PlGF protein were both persistently upregulated 20–
60 and 4–20 fold, respectively (Fig. 26A), with a comparatively modest 1.9 fold SDF1α 
peak induction. 
Continuous angiogenic growth factor expression led us to determine endothelial 
proliferation kinetics. Initiation of endothelial proliferation required 24hr of transgene 
activation (Fig. 26B and Fig. S4D). Proliferation peaked on d3 but exponentially 
decreased thereafter (Fig. 26B). As prolonged endothelial cell VEGF stimulation can 
produce divergent effects on VEGFR2 protein expression, either downregulation99, 100 or 
induction and maintenance,101 we hypothesized that diminution of receptor expression or 
activation would be associated with cessation of proliferation in TetON-HIF-1 
endothelium. However, whole tissue levels of both total and Y1173 VEGFR2 in DOX d0–
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60 TetOn-HIF-1 ears were persistently elevated 6–10 fold compared to controls (Fig. 26C 
and Fig. S5A). Fluorescence microscopy demonstrated persistent endothelial VEGFR2 
expression and receptor upregulation in perifollicular and subepidermal endothelial cells 
(Fig. S5B). Confocal microscopy revealed temporally regulated VEGFR2 intracellular 
compartmentalization. VEGR2 was induced and localized in paranuclear vesicles on d3 
(Fig. S5C, arrowheads), then redistributed throughout the cytoplasm and plasma 
membrane from d14–30. The major VEGFR2 signaling outputs, AKT, Src, PLCγ, and 
ERK phosphorylation, each persistently increased 2–6 fold, from d1 to d30 (Fig. 26C and 
Fig. S5A). Cyclin D1 was also persistently upregulated 2–6 fold following transgene 
induction (Fig. 26C and Fig. S5A). Immunofluorescence localized cyclin D1 expression 
to TetON-HIF-1 endothelial cell nuclei (Fig. 26D). Thus neither downregulation of 
VEGFR2 expression, activation, and signaling outputs, nor persistent G1 activation, was 
responsible for the temporally regulated, intrinsic endothelial cell proliferative resistance 
in the context of continuous angiogenic growth factor stimulation.  
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Fig. 26. Upregulation of HIF-1 angiogenic factor transcriptional targets, persistent 
VEGFR2 signaling and intrinsic downregulation of endothelial proliferation in TetON-
HIF-1 transgenic mice. (A) Ear tissue ELISA’s for VEGF (left), PIGF (middle) and 
SDF1 (right). Immediate d1 increase of VEGF and PlGF contrasts the gradual SDF1 
induction between d3–30. (B) TetON-HIF-1 endothelial cell proliferation kinetics 
determined by counting double-labeled BrdU/MECA32 (+) endothelial cells in 4–6 10X 
fields per thin section normalized to the microvascular density. (C) Representative 
Western blot analysis of total ear tissue lysates for VE-Cadherin, total and 
phosphorylated: VEGFR2(Y1173), PLCγ(Y783), ERK1/2(T202/Y204), and AKT(S473), 
and cyclin D1. (D) Representative immunofluorescent images (top) and quantification 
(bottom) of cyclin D1. TetON-HIF-1 data at each DOX day were compared with NTG or 
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TetON-HIF-1 d0 data (data not shown), using unpaired Student’s t-test (*P<0.05, 
**P<0.01 and *** P<0.001). Bar: 100 µm. 
 
To further probe mechanisms of endothelial proliferation downregulation, we 
determined the kinetics of cell cycle repressors in TetON-HIF-1 tissue extracts. Activated 
phospho-p53S20 was elevated 3-fold coincident with d3 peak endothelial proliferation, 
and remained 3–7 fold increased to d30 (Fig. 27A and Fig. S6A). The p53 target p21 was 
also induced 4-fold at peak endothelial proliferation and remained persistently elevated 
(Fig. 27A and Fig. S6A). Immunofluorescence revealed p21 induction and persistence in 
endothelial cell nuclei [Fig. 27B (white arrowheads), and Fig. 27D]. As these data 
suggested replication stress as a mechanism for cell cycle inhibition, we probed tissue 
extracts for activation of the stress/DNA damage mediator γH2AX. γH2AX was induced 
50-fold by d3, with further increases in protein expression between d14-30. Expression at 
d60 remained 16-fold elevated compared to d0 (Fig. 27A and Fig. S6A). 
Immunofluorescence also revealed endothelial cell nuclear γH2AX induction [Fig. 27C, 
(white arrowheads)]. Quantitative analysis delineated a 5-fold elevation of γH2AX 
positive endothelial cell nuclei by d3 and sustained at that level thereafter (Fig. 27D). 
Further analysis of the d0 and d3 time points using confocal microscopy, identified 
endothelial cells containing multiple γH2AX positive nuclear foci (Fig. S6B, and data not 
shown).  
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Fig. 27. Activation of epithelial HIF-1 induces a DNA damage/replication stress 
checkpoint. (A) Western analysis of p21, total and phosphorylated p53S20, 
phosphorylated γH2AX, reveals induction of cell cycle inhibitors consistent with 
replication stress beginning at peak endothelial proliferation (Fig. 26). (B–C) 
Representative thin ear tissue immunofluorescent images of p21 (B) and γH2AX (C). 
White arrowheads point to p21 and γH2AX positive endothelial cells. (D) Quantification 
of p21 and γH2AX expression determined by vessel counting of MECA32/p21 and 
MECA32/γH2AX double immunofluorescence tissue sections ex vivo. TetON-HIF-1 data 
at each DOX day were compared with TetON-HIF-1 d0 data, using unpaired Student’s t-
test (*P<0.05, **P<0.01 and *** P<0.001). Bar: 50 µm. 
 
1.2.6. Stage-specific differential responsiveness to VEGFR1/2 inhibitors 
TetON-HIF-1 multistage angiogenesis was a unique platform to temporally dissect the 
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functional contributions of VEGFR2 or VEGFR1 signaling to neovascularization. Day 0–
14 VEGFR2 immunoblockade with DC101102 produced a 2.3-fold reduction in 
microvessel density primarily due to inhibition of perifollicular neovessel formation (Fig. 
28A, B, and Fig. 29A). Western blotting revealed a 10-fold diminution of VEGFR2 
phosphorylation in this same interval (Fig. 28C, and data not shown).  In vivo, 
noninvasive L-PAM image extraction analysis detected a 2.9-fold diminution in capillary 
volume that nearly matched microvessel counting of tissue sections, whereas elevated 
arteriovenous and total vessel volumes were unaffected (Fig. 28B). VEGFR1 blockade by 
MF1103 did not affect d0–14 microvessel density (Fig. 29A), while a DC101/MF-1 
cocktail was similar to single-agent DC101 (data not shown).  
In contrast to d0–14, there was resistance of the TetON-HIF-1 microvasculature 
to either single-agent DC101 or DC101/MF-1 cocktail deployment between d14–28 that 
was also evident in the L-PAM data sets (Fig. 28A, B, and Fig. 29A). Microvessel 
density was reduced by only 20% compared to DTG d30 (Fig. 28B, left-most bar graph). 
Western analysis also mirrored resistance with a 2.5-fold reduction in phospho-VEGFR2 
(Fig. 28C). L-PAM microvessel subset extraction analysis revealed only a 1.9-fold 
reduction in capillary, and essentially unchanged arteriovenous volumes during VEGFR2 
(Fig. 28B) or combinatorial VEGFR1/2 blockade (data not shown). MF1 increased 
microvascular density by 30% during d14–28 (Fig. 29A, and data not shown), consistent 
with VEGFR1 function as VEGF “sink” on endothelial cells.  
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Fig. 28. Stage-specific resistance of the HIF-1 neovasculature to VEGFR1 and VEGFR2 
immunoblockade. (A) Inhibition of the development (d0−14) versus resistance of the 
maintenance stage (d14−28) to VEGFR2 (DC101) immunoblockade as determined by 
lectin whole mount and L-PAM analysis. Both L-PAM and FITC-Lysopersicon 
esculentum perfused whole mounts demonstrate the marked sensitivity of perifollicular 
neocapillaries, while microvessels farthest from HIF-1 production are resistant to DC101. 
L-PAM also detected arteriolar and venular dilatation resistant to DC101 treatment in 
both stages. (B) Quantification of diminution of microvessel density by cross sectional 
MECA32/vWF immunofluorescence (white bars, immunofluorescence data not shown) 
or volume reduction delineated by image extraction L-PAM analysis during d0–14 (top) 
or d14-28 (bottom) VEGFR2 blockade (blue and yellow bars). (C) Western blotting 
analysis of vascular endothelial-cadherin (VE-Cadherin), VEGR2Y1173 and total VEGFR2 
in mice treated with VEGFR1/2 blocking antibodies. Bars: 200 µm. 
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1.2.7. Stage-specific myeloid cell inhibitor responsiveness and dissociation of 
myeloid cells from neovascular development or maintenance  
As myeloid cells enhance tumor or ischemic angiogenesis,104 and contribute to 
angiogenic inhibitor evasion,105 we tested for their recruitment and retention from d0–30 
of HIF-1 activation. CD45, CD11b myeloid cells, mast cells and F4/80 macrophages 
were progressively recruited to the stroma during the TetON-HIF-1 d0–14 development 
stage, and were retained during the d14–30 maintenance stage (Fig. 29A, Fig. S7A, B, 
and Fig. S8C). Neutrophils were also recruited and retained during these stages though to 
a lesser extent than CD11b cells or F4/80 macrophages (Fig. S7C). Myeloid cell retention 
required continuous epithelial HIF-1 expression, as they rapidly disappeared from the 
stroma after 3 days, and returned to baseline levels by 14 days of DOX withdrawal (Fig. 
29A). 
To determine mechanisms of myeloid cell recruitment and retention, we first 
tested for endocrine angiogenic growth factor secretion from DOX-activated skin. There 
was a rapid 2.5- and 15-fold elevation of plasma VEGF and PIGF, respectively, on DOX 
d1, both falling to control levels by d30 (Fig. 29B). In contrast, plasma SDF1 was only 
1.4–1.5 elevated on d3 and 14, returning to baseline by d30 (Fig. 28C, right panel). 
Transient elevation of these angiogenic growth factors in plasma contrasted with their 
continual high-level expression in tissue (Fig. 26A, and Fig. S4A–C). Peak splenic 
enlargement followed peak growth factor plasma levels by two days, gradually 
decreasing by d30; associated with an increase in red pulp and perifollicular 
accumulation of F4/80 and CD11b macrophages (Fig. S8A, data not shown). A bone 
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marrow origin for the recruited myeloid cells was suggested by autologous bone marrow 
transplantation using CAG-EGFP donor cells (Fig. S7D).  
As previous work demonstrated the principal involvement of the 
VEGF/PlGF/VEGFR1 signaling module in recruitment,106 and SDF1/CXCR4 
engagement in retention,79, 107 we tested inhibitors of these signaling axes in both the 
development and the maintenance stages. As expected, either MF1-mediated VEGFR1 or 
DC101-mediated VEGFR2 immunoblockade abrogated myeloid cell recruitment during 
the development stage (Fig. 29A). However, the presence of robust neovascularization in 
the absence of stromal myeloid cells revealed by VEGFR1 blockade was unexpected (Fig. 
29A). CXCR4 blockade by AMD3100 did not alter development stage myeloid cell 
recruitment or neovascularization (Fig. 29A). While maintenance stage myeloid cell 
retention was unaffected by either single-agent DC101 or MF-1, it was nearly abrogated 
by a DC101/MF1 “cocktail” (Fig. 29A, and Fig. S8C). Potent inhibition of myeloid cell 
retention again revealed a striking disconnection between loss of stromal myeloid cells 
and persistence of the HIF-1 neovasculature. AMD3100, used at doses previously shown 
to decrease tumor and VEGF-mediated myeloid cell retention and hypervascularity,79, 88 
failed to affect either myeloid cell or microvascular density in the maintenance stage (Fig. 
29A, and Fig. S8C). Consistent with its low level induction by ELISA and AMD3100 
treatment resistance, SDF1, though upregulated in TetOn-HIF-1 basal keratinocytes (Fig. 
S8B) was rarely detectable in perivascular79 or endothelial cells.107 
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Fig. 29. Stage-specific regulation of stromal myeloid cell recruitment and retention, and 
model of epithelial neovascularization regulated by HIF-1. (A) Representative 
CD31/CD11b co-immunofluorescence demonstrating recruitment and stromal 
accumulation of CD11b myeloid cells during the TetON-HIF-1 DOX d0–14 neovascular 
development stage, with HIF-1-dependent retention of these cells from d14–28. Myeloid 
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cell recruitment is dependent on either VEGFR1 (MF1) or VEGFR2 (DC101), but 
independent of CXCR4 (AMD3100) signaling. Note that in MF1-treated TetON-HIF-1 
mice neovascular development proceeds despite marked inhibition of myeloid cell 
recruitment. DOX d14–28 myeloid cell retention is independent of either VEGFR1 or 
VEGFR2, but dependent on signaling from both receptors. Myeloid cell retention is only 
partially inhibited by AMD3100 (even less evident in CD45 immunofluorescence, Fig. 
S8). Note the persistence of maintenance stage neovasculature despite profound stromal 
myeloid depletion in the d14–28 DC101/MF1 inhibitor cocktail treated TetON-HIF-1 
mice. Marked stromal myeloid cell depletion following 3 (14/3) and 14 (14/14) days of 
DOX withdrawal. (B) Plasma VEGF (left), PIGF (middle) and SDF1 (right) expression 
levels in TetON-HIF-1 mice and DOX NTG controls determined by ELISA. (C) 
Continuous HIF-1 activation produces multistage intrinsically regulated neovascular 
development, maintenance, and transgene dependent regression. Mechanisms of myeloid 
cell recruitment and retention were stage-specific. Resistance to VEGFR2 
immunoblockade was also stage-specific. The cyan bar indicates peak proliferation 
achieved at d3. The dark orange arrow depicts neovascular growth and maintenance 
independent of myeloid cells. The purple arrow denotes 14 days of continuous DOX 
induction, while the purple bar signifies 14 days of DOX withdrawal. The yellow bar 
peak indicates peak apoptosis and L-PAM-determined capillary luminal constriction 
three days post DOX withdrawal. TetON-HIF-1 data at each DOX day were compared 
with NTG or TetON-HIF-1 d0 data (data not shown), using unpaired Student’s t-test 
(*P<0.05, **P<0.01 and *** P<0.001). Bars: 200 µm. 
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1.3 Discussion 
Here, using detailed kinetic analysis, we discovered that neovascular development was 
intrinsically regulated by a DNA damage checkpoint in endothelial cells coincident with 
peak endothelial proliferation. Each neovascular stage also possessed distinctive vascular 
and myeloid cell responses to angiogenesis inhibitors (Fig. 29C). TetON-HIF-1 mice 
enabled development of L-PAM, which noninvasively and without intravenous contrast, 
mapped neovascular network architecture and vessel volumetric changes during 
emergence, maintenance, regression, or angiogenesis inhibitor responsiveness.  
Cell autonomous inhibition of TetON-HIF-1 endothelial cell proliferation was 
surprising given the continuous microvessel exposure to elevated levels of angiogenic 
factors. Persistent VEGFR2 expression and activation was unexpected, because RTKs as 
a class are downregulated via internalization and degradation following growth factor 
activation.108 However, VEGFR2 cell biology is complex, with contextual regulation of 
expression level, intracellular compartmentalization, and signaling.99, 101, 109 Our study 
was a first in kind demonstration of in-vivo VEGFR2 internalization to paranuclear 
vesicles, consistent with either caveosomes or endosomes. These data suggested that 
VEGFR2 redistribution from the vesicular compartment to the plasma membrane could 
be responsible, in part, for the diminution of endothelial cell proliferative signaling in 
tissues as implied by several studies using cultured endothelial cells.110-112 However, a 
more attractive mechanism for cell autonomous regulation of endothelial proliferation 
was induction of replication stress due to continuous endothelial cell stimulation by 
angiogenic growth factors, here predominantly VEGF.113 Support for this hypothesis was 
based on several pieces of data, including persistent VEGFR2 expression and 
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phosphorylation, continuous cyclin D1 upregulation in endothelial cells, and induction 
and sustained expression of endothelial cell p21 and γH2AX. Localization of γH2AX to 
nuclear foci, consistent with DNA strand breaks, was also compelling data in support of 
replication stress.114 Prior work demonstrated that γH2AX was required for 
neovascularization in ischemia and in growing tumors.115 However that work suggested 
that γH2AX predominantly regulated endothelial proliferation during hypoxia. Here we 
demonstrated that replication stress and γH2AX were likely important for regulation of 
endothelial proliferation in normoxia and in response to continuous angiogenic factor 
stimulation. One possible mediator of endothelial cell replication stress is HIF-1α. HIF-
1α can induce a DNA damage response, in the absence of hypoxia, due to inhibition of 
Nbs1, a crucial component of the MRN DNA repair complex.116 As HIF-1 is also a part 
of a VEGF-mediated autocrine signaling loop in endothelial cells,87 MRN inhibition may 
be responsible for γH2AX induction in our model, and will be investigated in future 
studies. Collectively, these studies and our data highlight the ability of conditional 
models of neovascularization to uncover endothelial cell regulation mechanisms that are 
independent of disease. 
The endothelial-pericyte biology during epithelial HIF-1-mediated 
neovascularization was unanticipated. Lack of detectable “naked” endothelial tubes 
subsequently recruiting pericytes was contrary to studies of the neonatal rodent retina.96, 
117 However, coincident pericyte-endothelial envelopment during microvessel assembly 
and pericyte-mediated endothelial tip cell guidance during stromal invasion have both 
been reported.118-120 Intimate microvessel envelopment was also unexpected as HIF-1 
created a tumor-like angiogenic growth factor milieu, which has been correlated with 
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loose pericyte-endothelial association.121 Most surprising was the dissociation of pericyte 
coverage, transgene-dependent neovascular regression, and VEGF inhibitor resistance. 
As such, pericytes and vessel “maturation” could have been evoked as an explanation for 
VEGFR2 inhibitor resistance. However extensive pericyte coverage was insufficient to 
maintain the neovasculature following HIF-transgene withdrawal.  
Stage-specific alteration of VEGF receptor regulation of stromal myeloid cell 
recruitment and retention was also unanticipated. Prevention of stromal myeloid cell 
recruitment in the development stage by MF1 was consistent with known mobilization 
and chemotactic functions of VEGFR1 on hematopoietic precursors.122 DC101’s 
inhibition of d0-14 myeloid cell recruitment was consistent with an abrogation of both 
endothelial cell luminal receptor upregulation and VEGF proinflammatory functions.90 In 
contrast, maintenance stage myeloid cell retention was resistant to either MF1 or DC101, 
but exquisitely sensitive to dual VEGFR1/VEGFR2 immunoblockade. Previous work 
demonstrated VEGFR2 expression on tumor infiltrating myeloid cells.123 Our data now 
suggest a functional role for VEGFR2 expression in myeloid cell retention that will need 
to be tested in disease models. Equally surprising was the minimal effect of CXCR4 
blockade, particularly on myeloid cell retention. These results were in contrast with the 
potent ability of CXCR4 blockade to decrease both stromal myeloid cell retention and 
microvascular density in ischemia, tumor xenografts, and conditional VEGF induction 
models.79, 88, 107 Our study suggests that SDF-1 signaling requirement for myeloid 
retention is cell context, tissue, and disease dependent. Most surprising was the 
persistence of the HIF-1 microvasculature during maintenance stage DC101/MF-1-
mediated myeloid cell depletion, as these cells are the source of multiple angiogenic 
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factors responsible for VEGF inhibitor evasion or amplification of therapeutic 
angiogenesis in preclinical tumor or ischemia models.88, 107, 124, 125 As such, our work 
highlights the fact that myeloid cell accumulation in angiogenic tissues does not 
necessarily support neovascular persistence. Rather the bona fide ischemic or tumor 
microenvironment is required for proangiogenic myeloid cell subset production.  
PAM, combining optical excitation and ultrasonic detection has multiple 
attractive features. First, the endogenous hemoglobin absorption contrast enables PAM to 
identify RBC-perfused microvasculature, the functional vascular subset responsible for 
tissue oxygen supply.126 Second, the one-way ultrasonic path enhances tissue 
transparency because acoustic scattering in biological tissues is much weaker (1000 times 
less) than optical scattering. Third, the combination of the high nonradiative quantum 
yield of hemoglobin, the perfect 100% sensitivity of PAM to optical absorption, and the 
enhanced tissue transparency enables imaging sensitivity down to the single RBC level 
with a low laser exposure (contrast-to-noise ratio is ~100:1 with 570-nm laser 
excitation).127 Fourth, the combination of the contrast-free preparation and low-level laser 
exposure enables noninvasive repetitive imaging of chronic processes including, but not 
limited to, temporal angiogenesis. With the present L-PAM, we were able to dissect 
neovascular elaboration in TetON-HIF-1 mice at the capillary level in the same animal 
for prolonged observation intervals (60 days, or more if necessary). The feature 
extraction capability of L-PAM enabled determination of the differential responsiveness 
of capillaries versus arteriovenous vessels to angiogenic inhibitors. Emergent 
translational L-PAM advances are focusing on imaging and therapy monitoring for skin 
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cancer, breast cancer, and internal yet endoscopically accessible organs such as 
esophagus, colon, and bladder in cancer patients. 
 
1.4 Conclusion 
In summary, the TetON-HIF-1 mouse model revealed novel aspects of neovascular 
regulation divergent from previous preclinical studies but strikingly convergent with 
clinical challenges, facing both angiogenesis inhibitors in cancer and vascular restoration 
in ischemia. L-PAM’s ability to both longitudinally image neovascularization and to 
segment microvessel subset responses to angiogenesis inhibitors dynamics will be a boon 
to the study of ischemic and tumor neovascularization. 
 
1.5 Supplementary Figures 
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Fig. S1. Relationship of transgene expressing epithelial cells and neocapillary genesis in 
TetON-HIF-1 mice. (A) Representative ear whole mount demonstrating decoration of the 
K14/K5 (here K14) follicle outer root sheath keratinocytes and sebaceous glands (green) 
by CD31 (+) microvessel endothelial cells (red). Keratins -14 and -5 are coordinately 
expressed, and in TetON-HIF-1 mice the green cells express the HIF-1α transgene. (B) 
Representative whole mount CD31 immunofluorescence showing endothelial tip cells 
sprouting towards HIF-1-transgene expressing basal and sebaceous gland cells. Bars: (A), 
50 µm; (B), 20 µm. 
 
 
Fig. S2. Schematic of the L-PAM and differential capillary versus arteriovenous 
responsiveness to epithelial HIF-1 activation elucidated by L-PAM image extraction 
analysis. (A) A schematic of the L-PAM system. A short-pulsed laser beam is spatially 
filtered through a pinhole, and then is focused by a microscope objective to achieve 
micrometer resolution in living tissues. Wideband ultrasonic waves (referred to as 
photoacoustic waves) are induced as a result of transient thermoelastic expansion due to 
the laser excitation, and then detected by a high-frequency ultrasonic transducer to reveal 
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physiologically specific absorption properties of the tissue. (B) The depth-projected 
microvasculature of a DOX d14 TetON-HIF-1 mouse ear imaged with L-PAM. (C) 
Representative L-PAM images of an NTG mouse maintained on DOX from d0–60 
demonstrates an unchanged microvasculature network. (D) Image extraction of L-PAM 
data to delineate arteriovenous truncal vessels (left column) versus capillaries in NTG 
and DOX d14 TetON-HIF-1 mice (right column). The capillaries are clustered consistent 
with localization in perifollicular microdomains as in Fig. 2C. (E) Quantitative analysis 
of extracted L-PAM data showing the initial increase and then plateau in vascular volume 
over time. Total vascular volume is biased by arteriovenous values, as they collectively 
comprise most of the total vascular volume. Note the marked differential fold elevation of 
capillary versus total vessel or arteriovenous volumes. These data are consistent with de 
novo development and persistence of perifollicular microdomains, in contrast to 
expansion and increased tortuosity of preexisting arteries, arterioles, veins and venules. 
(F). Vessel-axis tracing based on the extracted L-PAM data enables quantification of the 
vessel length (red curve in panel D) between two adjacent bifurcation points. (G). The 
ratio between the vessel length and the linear distance (green curve in panel D) represents 
vessel tortuosity. Bars: 500 µm. 
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Fig. S3. Epithelial HIF-1 activation produces both transgene dependent and independent 
vessel subtypes, and dynamic alterations of pericyte marker expression over time. (A) 
FITC-Lysopersicon esculentum perfused ear whole mounts demonstrate perifollicular 
neocapillary development between d0–14, microvessel dropout evident by withdrawal 
day 3 (14/3), and persistence of the neovasculature that developed at a distance from the 
hair follicle units after 14 (14/14) or 28 (14/28) days of DOX withdrawal. DOX 0–14 
VEGFR2 blockade (DC101) produces a similar microvascular pattern as 14 or 28d 
withdrawal with extensive central microdomain ablation. (B) Representative dual 
MECA32/Desmin (left column) or PDGFRβ (middle column) or NG2 (right column) 
immunofluorescent images. Desmin expression is persistent throughout the course of 
neovascular development and maintenance in TetON-HIF-1 mice. In contrast, HIF-1 
activated pericytes incrementally express PDGFRβ and NG2 during the DOX d0–14 
development stage, followed by downregulation of these markers during the DOX d14–
30 maintenance stage. Bars: (A), 100 µm; (B), 200 µm. 
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Fig. S4. DOX induction of HIF-1 pro- and anti-angiogenic target genes, and 
endothelial/perivascular cell proliferation. (A-C) RT-PCR determination of differential 
patterns of HIF-1 target gene mRNA upregulation (A-B), or diminution (C). (D) Dual 
MECA32/BrdU immunofluorescence demonstrating activation of endothelial 
proliferation 36–48hr following DOX provision, peak proliferation on d3 and decrease to 
baseline by d30–60. TetON-HIF-1 data at each DOX day were compared with NTG, 
using unpaired Student’s t-test (***P<0.001, **p<0.01, * P<0.05). Bar: 200 µm. 
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Fig. S5. Epithelial HIF-1 activation results in persistent VEGF-VEGFR2 signaling 
pathway activation. (A) Quantification of Western blot detection of total VEGFR2, 
differential phosphorylation of VEGFR2Y1173, PLCγY783, ERKT202/204, AKTS473 and cyclin 
D1 induction and persistence. Immunoblots were adjusted for sample loading based on β-
tubulin densitometry, and then ratios of phospho to total proteins were normalized to 
NTG DOX or d0 ratios. Graphs are representative of 2–4 independent experiments.  (B) 
Dual CD31/VEGFR2 immunofluorescence shows progressive total VEGFR2 
upregulation, with redistribution and persistent VEGFR2 expression in perifollicular 
endothelial cells. (C) Intracellular paranuclear vesicular localization of VEGFR2 
(arrowheads) in TetON-HIF-1 mice on DOX d3 with more uniform distribution by DOX 
d14–30, determined by confocal microscopy of dual CD31/VEGFR2 
immunofluorescence in ear whole mounts. Bars: (B), 200 µm, inset 50 µm; (C), 20 µm. 
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Fig. S6. Identification and quantification of endothelial cell replication stress in response 
to HIF-1 induction. (A) Quantification of immunoblots presented in Fig. 26. (B) 
Representative confocal fluorescent images of γH2AX localized to nuclear foci in d3 
TetON-HIF-1 endothelial cells. TetON-HIF-1 data at each DOX day were compared with 
TetON-HIF-1 d0 data, using unpaired Student’s t-test (***P<0.001, **p<0.01, * P<0.05). 
Bar: 50 µm. 
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Fig. S7. DOX induction leads to stromal macrophage, mast cell, neutrophil, and bone 
marrow-derived cell recruitment. (A) Dual CD31/F4/80 immunofluorescence 
demonstrating d0–14 macrophage recruitment and d14-28 retention in TetON-HIF-1 
transgenic mice. (B-C) Mast cells [toluidine blue (+)] are also recruited and retained from 
d0–30 (B), though to a lesser extent than 7/4(+) neutrophils (C). (D) Differential 
perivascular GFP(+) bone marrow derived cell recruitment and retention. In-vivo 
isolectin B4 (IB4) perfusion delineates the microvasculature. Bars: (A–C), 200 µm; (D), 
100 µm. 
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Fig. S8. DOX induction leads to splenomegaly, increased SDF-1α expression and stromal 
CD45+ myeloid cell recruitment. (A) Splenic weights in DOX-treated TetON-HIF-1 
transgenic mice compared to treatment and time controls. Peak size is attained coincident 
with peak d3 endothelial cell proliferation (left panel). Representative spleens from either 
an NTG or a TetON-HIF-1 transgenic mouse both treated with DOX for 3d (right panel). 
Splenic histology from the corresponding DOX d3 NTG and TetON-HIF-1 mice (bottom 
right panel) showing cortical hyperplasia in the TetON-HIF-1 spleen (blue arrows, 
lymphoid follicles, green arrows, increased megakaryocytes).  (B) Representative dual 
CD31/SDF-1 immunofluorescence of ear cross sections showing incremental SDF-1 
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expression from d3–14, plateauing at d30 in TetON-HIF-1 compared to NTG mice. 
Notably, SDF-1 upregulation is predominantly restricted to basal keratinocytes, with rare 
endothelial cell SDF-1 co-immunofluorescence (top four panels and insets). Robust SDF-
1 expression in positive control tissues, brain (bottom left panel) and splenic cortex 
(bottom right panel). (C) Representative CD31/CD45 co-immunofluorescence 
demonstrating recruitment and stromal accumulation of CD45 myeloid cells during the 
TetON-HIF-1 DOX d0-14 neovascular development stage, with HIF-1-dependent 
retention of these cells from d14–28, similar to CD11b+ myeloid cell biology described 
in Figure 7A. Notably, myeloid cell retention is only slightly inhibited by AMD3100, 
Bars: (A-C), 200 µm. (B), 50 µm, upper four insets, 100 µm lower two insets. 
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2. VEGF is essential for HIF-mediated neovascularization*
To test the role of VEGF during epithelial HIF-1 induced neovascularization, we 
combined our previously described TetON-HIF-1 mice with K14-Cre transgenic and 
VEGF floxed knock-in mice.93, 128-130 The final genotype of these composite mice is K14-
rtTA:TRE:HIF-1αP402A/P564A/N803A:K14-Cre:VEGFf/f. The use of the HIF-1α triple mutant 
stabilized HIF-1 protein and rendered transcriptional activity insensitive to oxygen.131 We 
designated this genotype as TetON-HIF1:VEGFΔ.  
 
The segmentation capability of OR-PAM enabled determination of multiple 
parameters of vascular morphology including capillary volume as an indicator of 
angiogenesis, and arteriovenous (arteriolar/venular) volume, vessel length, diameter and 
tortuosity as measures of vascular remodeling. Serial PAM monitoring of individual mice 
from d0–60 of continuous DOX provision revealed that HIF-1 activation in TetON-HIF-
1:VEGFf/f mice produced a marked 8-fold increase in capillary, a 3.5-fold elevation of 
arteriovenous and overall vascular volume (Fig. 30A and B). Three dimensional vessel 
segmentation analysis demonstrated abrogation of HIF-1-ediated vasodilatation and 
tortuosity induction in the absence of epithelial VEGF (Fig. 30B).   
Topical phorbol ester induces angiogenesis via enhanced VEGF secretion from 
the activated epithelium.132, 133 This is a transient phenomenon resolving within 3–4 days 
following single dose treatment. Previously, we discovered that germline transgenic mice 
constitutively expressing a stabilized HIF-1α mutant responded to single dose TPA 
challenge with a marked and prolonged stromal and intraepithelial neutrophil infiltrate 
                                                 
* Reprinted with permission from Sunday Oladipupo, Song Hu, Joanna Kovalski, Junjie Yao, 
Andrea C. Santeford, Rebecca E. Sohn, Konstantin Maslov, Lihong V. Wang, and Jeffrey M. 
Arbeit, “VEGF is essential for hypoxia-inducible factor mediated neovascularization but 
dispensible for endothelial sprouting,” (Submitted). 
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persisting for three weeks.134 Neutrophil recruitment was secondary to HIF-1 enhanced 
NfkB signaling and downstream chemokine production by transgenic keratinocytes. We 
capitalized on this strategy to determine if lack of HIF-1 mediated neovascularization in 
TetON-HIF1:VEGFΔ vasculature could be rescued. TetON-HIF1:VEGFΔ and TetON-
HIF-1:VEGFf/f were DOX-induced for 14 days to prime the keratinocytes and stroma, 
and emulate germline constitutive activation. A single dose of topical TPA was followed 
by harvest of the ears 10 days later for immunofluorescence analysis. TPA treatment did 
not further augment VEGF expression or neovascularization in TetON-HIF-1:VEGFf/f 
mice (Fig. 31A–C). In contrast, single dose TPA in TetON-HIF1:VEGFΔ mice produced 
a 2-fold increase in VEGF associated with a similar fold increase in neovessels. This 
partial rescue of HIF-1 mediated neovascularization in the absence of epithelial VEGF 
was associated with a marked influx of stromal neutrophils to levels similar to that of 
TPA-treated TetON-HIF-1:VEGFf/f mice. Restoration of the HIF-1 neovascular 
phenotype by chemokine-activated neutrophils was also associated an increase in 
capillary and total vessel volume, and in vessel tortuosity, as determined by OR-PAM 
(Fig. 31A and B). 
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Fig. 30. TetON-HIF1:VEGFΔ mice lacked vessel remodeling. (A) Angiogenesis 
determination and accompanying vascular remodeling by OR-PAM. OR-PAM was 
performed in the same VEGFf/f or VEGF∆ transgenic mouse serially imaged for 60 days 
(d0–30 are represented). Increased capillary density (asterisk) is evident particularly by 
d14, whereas arteriovenous remodeling is detectable at d14 and prominent by d30 
(arrow). (B) Quantification of (A) showing microvascular multi-parameter measurements 
from d0-60 (n=3 mice per time point, see Methods for more details). VEGFf/f or VEGF∆ 
data at each DOX day were compared with VEGFf/f d0 data using the unpaired Student’s 
t-test (*P<0.05, **P<0.01 and ***P<0.001). Scale bar: 500 µm. 
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Fig. 31. Topical TPA rescues HIF-1 neovascularization in VEGFΔ mice. (A) 
Angiogenesis determination and accompanying vascular remodeling in TPA-treated and 
non-treated VEGFf/f and VEGF∆ mice by OR-PAM. TPA partially rescued both capillary 
volume and arteriovenous remodeling. (B) Quantification for vascular parameters in (A). 
(n=3 mice). *P<0.05, **P<0.01 and ***P<0.001. Scale bar: 500 µm. 
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3. Longitudinal OR-PAM of tumor neovascularization*
As a preliminary study, OR-PAM imaged the microvasculature and the vessel-by-vessel 
sO2 of an A549 lung adenocarcinoma xenograft in a nude mouse ear (Fig. 32A–C). It is 
notable that the vessel sO2 map of this tumor xenograft histotype is similar to those of 
other xenograft models, a central hypoxic/anoxic core and an adequately oxygenated 
peripheral rim.  
 
Future study will focus on longitudinal determination of morphological (i.e., 
vessel diameter, length, tortuosity and volume) and functional (i.e., HbT, sO2, and blood 
flow) changes within individual microvessels during the entire process of tumor growth 
within the same animal will provide the unprecedented ability to test hypotheses directed 
at how the functional properties of the tumor neovasculature affect specific features of 
tumor cell and tissue biology. 
 
Fig. 32. (A) Coincident en face paraffin histopathology of an A549 lung adenocarcinoma 
tumor, (B) PAM imaged neovascular architecture and (C) vessel-by-vessel sO2. T: tumor; 
N: necrosis. Color bar in (C) indicates sO2 concentration.  
                                                 
* S. Hu et. al., Preliminary data. 
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IV. OR-PAM IN NEUROLOGY 
1. Intravital microscopy of amyloid plaques in a transgenic mouse model*
1.1 Introduction 
 
Amyloid-β, the primary constituent of senile plaques, is hypothesized to play a major role 
in the pathogenesis of AD, but the underlying mechanisms are still elusive. Recent 
advances in established clinical imaging modalities have permitted noninvasive imaging 
of amyloid deposits in patients.135 However, the neuropathologic changes in AD are 
microscopic, and subtle changes due to disease progression or treatment may be 
undetectable by such clinical instruments because of their low spatial resolutions. 
Multiphoton microscopy, a commercially available laser scanning microscopy technique, 
allows imaging of amyloid plaques with high sensitivity and sub-micrometer resolution 
in animal models.136 However, its applications are limited by the inability to image 
through the intact skull, thereby requiring cranial window preparations.  
Here, we report the first application of OR-PAM towards imaging amyloid 
plaques in an AD transgenic mouse model. OR-PAM images of Congo-red-stained brain 
sections from these mice were virtually identical to fluorescence images. Moreover, in 
vivo OR-PAM images through a cranial window also showed high correlation with 
observations by multiphoton microscopy. As a new technology for in vivo amyloid 
plaque imaging, OR-PAM provides both the exogenous molecular contrast from the 
amyloid-specific Congo red dye and the endogenous absorption contrast from 
                                                 
* Reprinted with permission from S. Hu†, P. Yan†, K. Maslov, J.-M. Lee, and L. V. Wang, 
“Intravital imaging of amyloid plaques in a transgenic mouse model using optical-resolution 
photoacoustic microscopy,” Opt. Lett. 34 (24), 3899–3901 (2009). † Authors contributed equally 
to this work. 
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hemoglobin, enabling simultaneous visualization of cerebral microvasculature without 
using angiographic dye. 
 
1.2 Methods 
Figure 33 shows a schematic of the OR-PAM system for intravital amyloid plaque 
imaging. To maximize the imaging sensitivity, optical illumination and ultrasonic 
detection in our OR-PAM system are configured confocally by an acoustic-optical beam 
splitter.137 The beam splitter is nearly transparent to the optical illumination, but the oil-
glass surface at the diagonal reflects almost all the ultrasonic signals to a 75 MHz 
ultrasonic transducer [V2022 (BC), Olympus NDT] attached to the vertical side of the 
bottom prism. The near-diffraction-limited optical focusing achieved by a commercial 
microscope objective (RMS4X, Thorlabs) determines the 5-µm lateral resolution of OR-
PAM. An acoustic lens (NA: 0.46) is attached to the bottom of the beam splitter and 
immersed in a water tank to collect photoacoustic signals. A window is opened in the 
bottom of the water tank and sealed with an ultrasonically and optically transparent 
polyethylene membrane to expose the imaging site. For simplification, the water tank is 
not shown in Fig. 33. Two-dimensional mechanical scanning of the animal along the 
transverse plane, in combination with time-resolved ultrasonic detection, provides 
volumetric resolution. Hence, no depth scanning is necessary. 
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Fig. 33. Schematic of OR-PAM for amyloid plaque imaging.  OR-PAM imaging and 
multiphoton imaging were performed through a cranial window preparation (inset). 
 
1.3 Results and Discussion 
In order to compare and validate OR-PAM with established fluorescence microscopy for 
imaging of amyloid plaques, a Congo-red-stained brain section from a 10 month-old  
APP/PS1 mouse (The Jackson Laboratory) was cover-slipped and examined using a 
fluorescence microscope (BX50, Olympus) equipped with a MicroFire® monochrome 
microscope digital CCD camera (Optronics) under Rhodamine excitation (496–540 nm). 
By measuring red fluorescence (520–625 nm), amyloid plaques were detected in 
APP/PS1 brain sections (Fig. 34A). A 1 × 1 mm ROI (enclosed by the red dashed box in 
Fig. 34A, and replotted in Fig. 34B for better comparison) was imaged by OR-PAM 
using a 523 nm wavelength (Fig. 34C). All amyloid plaques visualized using 
conventional fluorescence microscopy were observed with OR-PAM as well, suggesting 
that OR-PAM has the sensitivity and spatial resolution required to image amyloid plaques 
(a few representative plaques are paired up in Figs. 34B and 34C for comparison). The 
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main features of amyloid plaques in the two images were virtually identical (the 
correlation coefficient was calculated to be 0.95 based on both plaque size and location). 
 
Fig. 34. In vitro imaging of a Congo-red-stained brain section from a 10-month-old 
APP/PS1 mouse. (A) The entire hippocampus imaged using conventional fluorescence 
microscopy. (B) A region of interest selected from (A) (boxed area). (C) The same region 
of interest imaged by OR-PAM for comparison. Arrows: plaques. Scale bar in (A) applies 
for (A–C). 
 
To examine the plaque imaging capability of OR-PAM in living mice, OR-PAM 
images were directly compared with the images acquired by multiphoton microscopy. A 
10-month-old APP/PS1 mouse was injected with Congo red through the cisterna magna 
to label amyloid plaques in vivo. Twenty-four hours after injection, an open-skull cranial 
window covered by a plastic coverslip was created over the parietal cortex, and dye 
labeling was confirmed by conventional fluorescence imaging (Fig. 35A). An ROI 
(enclosed by the red dashed box in Fig. 35A) containing a variety of amyloid plaques and 
blood vessels was selected for both dual-wavelength OR-PAM imaging and multiphoton 
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imaging (LSM 510 META NLO system, Zeiss). Two-photon fluorescence was generated 
with 800 nm excitation (Chameleon Ti: Sapphire laser, Coherent) and detected in the 
spectral range of 565–615 nm. A maximum-intensity-projection image (Fig. 35B) was 
generated by a z-stack image series acquired from the cranial window surface to a depth 
of ~200 µm into the cortex.  The incremental z-step distance was 10 µm under a 10x 
water-immersion objective (NA: 0.33, Zeiss). For the dual-wavelength OR-PAM imaging, 
optical wavelengths of 570 nm (Fig. 35C) and 523 nm (Fig. 35D) were selected to 
differentiate the photoacoustic signals generated by hemoglobin and Congo-red-labeled 
amyloid plaques. Imaging depths of amyloid plaques and blood vessels were quantified 
to be 230 µm and 450 µm from the cortical surface, respectively. The absorption of 
Congo red at 523 nm is ~6 times higher than that at 570 nm;138 however, the absorption 
of hemoglobin differs by only 1.4 times.139 Moreover, at each wavelength, the optical 
absorption coefficients of HbO2 and HbR are nearly equal, so the blood photoacoustic 
signals reflect the total hemoglobin concentration regardless of the blood oxygenation 
level. Based on these two characteristics, the photoacoustic image taken at 523 nm was 
linearly scaled to equalize the blood vessel signals with their counterparts taken at 570 
nm, and then the two mutually normalized images were subtracted pixelwise to eliminate 
the blood signals and isolate the Congo-red-labeled amyloid plaques. Upon separating the 
distributions of the hemoglobin and the amyloid plaques, they were pseudocolored 
differently for clear visualization in both the MAP image (Fig. 35E) and the 3-D movie 
(data not shown). Images acquired using OR-PAM and multiphoton microscopy were 
directly compared, revealing excellent correlation in plaque distribution (arrows, Fig. 
35B, D and E). A few small plaques visualized using multiphoton microscopy (Fig. 35B) 
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were not detected by the OR-PAM system (Fig. 35E), most likely due to the limited 
signal-to-noise ratio caused by the non-optimized excitation wavelength for Congo red 
detection and by the interference from the strong blood absorption. It should be noted that 
the imaged plaque sizes are slightly different as measured by the two imaging modalities. 
This likely reflects differences in imaging contrast and sensitivity between the two 
techniques; however, since each plaque can serve as its own control for time-lapsed 
imaging, measures of relative plaque growth are expected to be similar.  
 
Fig. 35. In vivo brain imaging of a Congo-red-injected 10-month-old APP/PS1 mouse 
through a cranial window. (A) The exposed cortical brain region imaged using 
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conventional fluorescence microscopy through the cranial window. The region of interest 
marked by a red dashed box was imaged by (B) multiphoton microscopy, and OR-PAM 
at (C) 570 nm and (D) 523 nm, respectively. (E) The processed dual-contrast optical-
resolution photoacoustic microscopic image, where amyloid plaques are colored green 
and blood vessels are colored red (volumetric visualization is available online as Media 
1). Arrows: plaques. Scale bar in (B) applies for (B–E). 
 
Although the current configuration of OR-PAM has successfully demonstrated 
the ability to image amyloid plaques in vivo, transcranial imaging (through an intact 
skull) is certainly more attractive for minimally-invasively monitoring AD progression 
and drug efficacy. OR-PAM has already been shown to be capable of imaging individual 
capillaries through intact skulls in living adult mice.5 Thus, in vivo transcranial OR-PAM 
imaging of amyloid plaques, which are similar to or larger than capillaries, is highly 
likely with further optimization of imaging parameters and improvements in the optical 
absorption of amyloid-specific dyes as indicated below. 
One possible improvement would take advantage of the fact that the absorption 
spectrum of Congo red peaks at 500–510 nm, where hemoglobin experiences a local 
absorption valley.138, 139 Down-shifting the optical illumination wavelength of OR-PAM 
to 500–510 nm (not available in our current laser system) will increase the contrast 
between hemoglobin and Congo red by at least a factor of 4, which will help differentiate 
between amyloid plaques and blood vessels.  Another possible improvement is to modify 
the current acoustic detection mechanism to avoid the unnecessary transformation of the 
photoacoustic signals from p- to sv-waves, and to apply an ultrasonic antireflection 
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coating to the acoustic lens. Still another improvement is suggested by the Fourier 
analysis of our transcranial mouse brain imaging data, which shows that decreasing the 
center frequency of the ultrasonic transducer from current 75 MHz to 40 MHz is expected 
to further increase the detected photoacoustic signals by 2 fold at the expense of spatial 
resolution.  
Besides technical improvements to the OR-PAM system, developing amyloid-
specific dyes absorbing at the NIR optical window of biological tissues (700–800 nm) 
would be expected to further enhance in vivo amyloid plaque imaging.140 Tissue 
scattering and absorption within the NIR range are greatly reduced compared to that in 
the visible spectrum. Working in the NIR region with the aid of highly specific amyloid 
dyes will allow deeper tissue penetration and provide higher contrast between the 
targeted amyloid plaques and the surrounding tissues. 
 
1.4 Conclusion 
Advances in the above aspects will likely allow OR-PAM imaging of amyloid plaques 
through an intact mouse skull. This noninvasive imaging capability will eliminate the 
influence of the cranial window preparations on the underlying brain tissues. Recent 
studies suggest that invasive cranial window preparations may adversely influence 
underlying brain tissue behavior.81, 141 Furthermore, imaging through intact skull would 
greatly expand the available regions for imaging, thereby reducing the numbers of 
animals needed to quantify plaque growth. Such a model would be very attractive as an in 
vivo screen for drug development. 
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2. Intravital microscopy of microvascular responses to cortical electrical 
stimulation*
2.1 Introduction 
 
Neurovascular coupling links local neural activities with spatial-temporal changes in 
cerebral hemodynamics—including HbT, sO2, and blood flow.142, 143 This feature has 
been widely utilized by functional brain imaging techniques—such as MRI, DOT, and 
PAT—as a minimally invasive or non-invasive method to infer brain function.60, 144-146  
However, exploring the mechanism of neurovascular coupling at the microscopic 
level remains challenging. Clinical neuroimaging modalities (such as MRI and DOT) 
lack the spatial resolution for microvascular imaging,9 and high-resolution purely optical 
microscopy techniques (such as fluorescence microscopy and OCT) have limited access 
to hemodynamic parameters, especially sO2.1 PAT has the potential to overcome these 
limitations by enabling label-free quantification of cerebral hemodynamic changes in 
HbT, sO2, and blood flow velocity at various spatial scales.147 As a first-in-kind 
neurovascular study using photoacoustics, Wang et al. used PACT to observe the 
hemodynamic response of somatosensory cortex to mechanical stimulation of the rat 
whisker pad.146 Providing a spatial resolution comparable to clinical modalities (200 µm), 
the early-version PACT was not able to image the microvasculature itself. Later with AR-
PAM, Stein et al. demonstrated hemodynamic monitoring of individual vessels under 
hypoxic and hyperoxic challenges.148 Although having a much refined resolution (70 µm 
laterally), AR-PAM still has difficulty in resolving distal microvessels and single 
                                                 
* Reprinted with permission from Vassiliy Tsytsarev†, Song Hu†, Junjie Yao, Konstantin Maslov, 
Dennis L. Barbour, and Lihong V. Wang, “Photoacoustic microscopy of microvascular responses 
to cortical electrical stimulation,” J. Biomed. Opt. (Under review). † Authors contributed equally 
to this work. 
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capillaries, which are assumed to have the closest spatial correlation with neural 
activities.64 Recently, Maslov et al. developed OR-PAM.4 With diffraction-limited optical 
focusing, OR-PAM enables transcranial imaging of murine cerebral microvascular 
morphology and oxygenation at the resolution of individual capillaries.5 Quantitative 
monitoring of microhemodynamics, such as vasodilatation, vasomotion, and changes in 
blood flow, has also been documented with this technique.7, 12 
In this work, OR-PAM was used for the first time to explore neurovascular 
coupling at the microscopic level in a cortical electrical stimulation model. Direct 
electrical stimulation may cause cortical neurons to generate action potentials and 
synaptic release of various neurotransmitters, which can further react with nearby 
astrocytes, smooth muscle cells, and endothelial cells of the vessel wall.142 The net effect 
of these reactions drives cortical vessels from the resting state to either vasoconstriction 
or vasodilatation. Alternatively, smooth muscle cells and astrocytes can directly respond 
to electrical stimulation:149 direct electrical stimulation of smooth muscle cells may cause 
vasoconstriction, while direct electrical stimulation of astrocytes may result in 
intracellular calcium waves along the astrocytic syncytium, which may signal the release 
of various neuromodulators to direct blood vessels to regulate the metabolic supply by 
increasing or decreasing the local vessel capacity.150, 151 Moreover, electrical stimulation 
of brain tissue temporarily increases extracellular potassium concentration, which can 
potentially cause neural hyperactivity. Increased neural activity requires more blood flow, 
which may result in vasodilatation.142, 149, 151 Using OR-PAM, we observed both 
vasodilatation and vasoconstriction in response to cortical electrical stimulation. We 
further studied the electrical current dependence and the spatial-temporal characteristics 
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of these two types of microvascular responses, at both single-vessel and statistical (27 
vessels in total) levels. The results indicate that OR-PAM provides sufficient spatial 
resolution and adequate temporal resolution to study the coupling between neural 
activities and individual cortical microvessels. 
 
2.2 Methods 
Experiments were performed on three animals using our reflection-mode OR-PAM 
system (Fig. 36a), which has been described in detail previously.4, 5 Before each 
experiment, a Swiss Webster mouse (Hsd: ND4, 25–30 g; Harlan, Indianapolis, IN) was 
anesthetized by intraperitoneally administering a dose of 87 mg/kg ketamine and 13 
mg/kg xylazine. The animal was placed into a custom-made stereotaxic imaging stage, 
and the left dorsal portion of the skull was exposed by removing the scalp and temporal 
muscle. A cranial opening (~4×4 mm2) was made using a dental drill, and the exposed 
dura mater surface was cleaned with artificial cerebrospinal fluid. A monopolar tungsten 
electrode (impedance: 1 MΩ; tip diameter: 10 µm; MicroProbes for Life Science, 
Gaithersburg, MD) was introduced into the cortex to a depth of 0.1–0.2 mm through the 
opening to induce the preset electrical stimulation (Fig. 36b, c). Then, optically 
transparent ultrasonic gel was applied to the cranial opening for ultrasound coupling. 
Anesthesia was maintained using vaporized 1.0% isoflurane with an air flow rate of 1.0 
L/min. The body temperature of the animal was kept at 37°C by a temperature-controlled 
heating pad.  
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Fig. 36. (a) Schematic of the optical-resolution photoacoustic microscope. (b) Photograph 
of the exposed mouse brain surface with an introduced microelectrode. (c) Stimulation 
pattern. 
 
During each experiment, we first used an isosbestic wavelength of 570 nm to 
image the vascular system structure in a 2×2 mm2 cortical region through the cranial 
opening (Fig. 37, gray scale). Then, within a smaller ROI around the tip of the 
microelectrode, wavelengths of 570 nm and 578 nm were used to quantify sO2.152 The 
overlaid structural and sO2 (functional) images are shown in Fig. 37. Upon observing the 
vascular system structure and sO2 distribution, we randomly selected a B-scan crossing 
both arterioles and venules (indicated by the dashed line in Fig. 37) for hemodynamic 
monitoring with various stimulation intensities. Each monitoring trial lasted for 600 s 
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(300 B-scans at 570 nm), during which two identical electrical stimulation sequences 
were executed 200 s and 400 s after the first B-scan, respectively (Fig. 36c). Each 
stimulus consisted of a train of four identical square pulses (pulse duration: 0.3 ms; 
repetition rate: 300 Hz; current intensity: 100–400 µA) generated by a stimulator (A365; 
World Precision Instruments, Sarasota, FL) triggered by a function generator (DS345; 
Stanford Research Systems, Sunnyvale, CA). The time interval between two adjacent 
trials was 10 minutes. 
 
Fig. 37. Superimposed open-skull photoacoustic images of the mouse cortical 
microvasculature. The maximum-amplitude projection image acquired at 570 nm is 
shown in gray scale, and the vessel-by-vessel hemoglobin oxygen saturation mapping of 
a smaller region calculated from dual-wavelength measurements is shown in color scale. 
B-scan monitoring of the vascular response was performed along the yellow dashed line. 
V1 and V2 are the two microvessels studied in Fig. 38. 
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After image acquisition, photoacoustic amplitudes were extracted via the Hilbert 
transformation using the “hilbert” function in MATLAB (MathWorks, Natick, MA, 
USA). To distinguish vessels from background, we empirically set the amplitude 
threshold to be 3 dB above the noise level, which was defined as the standard deviation 
of the background noise amplitude. After converting the photoacoustic image into a 
binary image using the amplitude threshold, the cross section of each vessel was 
identified (i.e., segmentation) by 8-connected labeling using the Image Processing 
Toolbox in MATLAB. Because the transverse resolution of OR-PAM (5 µm) is much 
finer than the axial resolution (15 µm) and thus provides more accurate measurements, 
the vessel diameter was calculated along the transverse direction. The initial condition 
(baseline) was defined as the mean value of the vessel diameter before the first 
stimulation. To compensate for the slow baseline drift and the oblique angle subtended by 
the B-scan direction and the vessel axis, the time course of the vessel diameter was 
normalized to its baseline at each trial. Changes in vessel diameter were also normalized 
to the baseline. The duration of vasodilatation was defined as the period during which the 
vessel remained a response (in diameter) that is above 90% of the maximum response. 
The response time was defined as the period during which the vessel response changed 
monotonically from 10% to 90% of the maximum response; similarly, the recovery time 
was defined as the period during which the vessel response changed monotonically from 
90% to 10% of the maximum response. 
After each experiment, the animal was euthanized with an overdose of 
pentobarbital. All experimental animal procedures were carried out in conformance with 
the laboratory animal protocol approved by the School of Medicine Animal Studies 
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Committee of Washington University in St. Louis. 
 
2.3 Results and Discussion 
OR-PAM provides high spatial resolution, adequate temporal resolution, and a large 
FOV,5, 7 allowing us to study the responses of individual vessels at different spatial 
locations simultaneously. The present study investigated a total of 30 microvessels within 
1 mm of the stimulating electrode from 3 different animals. In response to intracortical 
electrical stimulation, 9 vessels showed only vasoconstriction, 15 showed only 
vasodilatation, 3 showed both, and the remaining 3 showed no response.  
Figure 38 demonstrates the vasoconstriction and vasodilatation of the same 
microvessel (V1 in Fig. 37) in response to electrical stimulations at different current 
levels. At 100 μA, a distinct vasoconstriction appeared after each of the two stimuli [Fig. 
38a). At 150 μA, the first stimulus produced a pronounced and prolonged vasodilatation, 
which prevented the vessel from recovering back to the resting state before the arrival of 
the second stimulus (Fig. 38b). Changes in vessel diameter were not clearly observed in 
the axial direction because the axial resolution (15 µm) of OR-PAM was not adequate to 
resolve such small changes. Note that the baseline diameters of the microvessel (defined 
as the average transverse dimension of the vessel prior to the first stimulation in each 
monitoring trial) were different between the two trials (the left panels in Fig. 38a, b), 
possibly due to the isoflurane anesthesia and the open-skull condition.153 Also note that 
the vessel cross sections in Fig. 38 appeared elliptic because the B-scan crossed the 
vessel at an oblique angle rather than a right angle. However, by normalization on initial 
condition, the influence of these two effects on the quantification of relative changes in 
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vessel diameter can be eliminated.  
 
Fig. 38. B-scan monitoring of vasoconstriction and vasodilatation induced by direct 
electrical stimulations at (a) 100 µA and (b) 150 µA (B-scan rate is 0.5 Hz). In each panel, 
the left column is the time course of the change in vessel diameter (represented by the 
projection of the vessel cross section). The right column is the vessel cross-sectional 
image at different time points, indicated by the green lines. The red lightning symbol 
indicates the onset of the stimulation. 
 
Figure 39a further shows the current-dependent response of microvessel V1. At 
100 μA (purple curve in Fig. 39a), a rapid vasoconstriction was induced right after each 
stimulus, with as much as an 18% decrease in vessel diameter; however, higher 
stimulation currents (from 110 μA up to 400 μA) led to a transition from rapid 
vasoconstriction to prolonged vasodilatation, with a diameter increase of as high as 87%. 
The normalized maximum diameter changes of V1 at a variety of stimulation currents 
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were plotted in Fig. 39b (red squares) and fitted with the smoothing spline function (red 
curve) in MATLAB. According to the fitting curve, the critical stimulation intensity 
corresponding to the transition from vasoconstriction to vasodilatation was estimated to 
be ~107 µA. Besides the transition in vascular response, the amplitude and the duration 
of vasodilatation of V1 were found to be non-monotonic with the current intensity [red 
curves in Fig. 39b, c). This non-monotonic response likely suggests both coexistence and 
competition between the two vascular regulation mechanisms: current-induced smooth 
muscle contraction and neuroactivity-induced vasodilatation. Interestingly, the other 
daughter vessel (V2 in Fig. 37), which bifurcated from the same parent vessel as V1, 
showed very similar responses (blue curves in Fig. 39b, c). The Pearson correlation 
coefficients of the current-dependent vasodilatation amplitude and duration were 
calculated to be 0.89 (p = 0.001) and 0.73 (p = 0.06), respectively, using a standard 
function called “corrcoef” in MATLAB. 
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Fig. 39. Current-dependent vascular response studied in individual microvessels. (a) 
Time courses of the diameter change in V1 under various stimulation intensities. (b and c) 
Correlation of the current-dependent vascular responses of two daughter vessels (V1 and 
V2) bifurcated from the same parent vessel: (b) normalized maximum diameter change 
and (c) the duration of vasodilatation. The two semi-transparent planes in panel (a) 
indicate the time points of the two stimuli. 
 
OR-PAM’s large FOV enabled exploration of the spatial features of the 
microvascular response. All 27 microvessels that showed responses in the 3 experiments 
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were studied in this way (Fig. 40 and Table 4). When microvessels were within 300 µm 
of the electrode tip, there was a clear transition from vasoconstriction to vasodilatation 
with increased stimulation intensity (blue bars in Fig. 40a and Table 4a). Throughout this 
transition, both the response amplitude and the number of responding vessels were 
diminished, suggesting a transition in the balance between current-induced smooth 
muscle contraction and neuroactivity-induced vasodilatation (blue bars in Fig. 40a, b). 
However, in vessels that were farther from the electrode tip (>300 µm), vasodilatation 
became more dominant. Another observation was that the total number of responsive 
vessels decreased with increased distance from the electrode tip, which likely reflected 
the decay of stimulation intensity due to the radial current diffusion (Fig. 40b and Table 
4b). 
 
Fig. 40. Spatial characteristics of vasoconstriction and vasodilatation at different 
stimulation currents studied in 27 microvessels. (a) Relative change in vessel diameter vs. 
distance from the electrode tip. (b) Number of responding vessels vs. distance from the 
electrode tip. For clarification, the relative diameter changes and the numbers of 
responding vessels are listed in Table 4a and 4b, respectively.  
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Table 4. Spatial characteristics of vasoconstriction and vasodilatation at different 
stimulation currents studied in 27 microvessels.  
(a) Relative change in vessel diameter vs. distance from the electrode tip. Values are in 
mean ± standard deviation format. 
 
                Distance (µm) 
Current (µA) 200 400 600 800 1000 
100 -0.26±0.48 0 0 0 0 
150 -0.50 0 0 0 0 
200 0 1.00 1.45±0.92 2.00 2.00 
250 0 1.00±0.71 0.60 1.50 0 
300 0.10±0.95 2.00±0.50 0 0 0 
 
 
(b) Number of responding vessels vs. distance from the electrode tip. 
                    Distance (µm) 
Current (µA) 200 400 600 800 1000 
100 7 0 0 0 0 
150 1 0 0 0 0 
200 0 1 6 1 1 
250 0 2 1 1 0 
300 3 3 0 0 0 
 
The temporal features of vasodilatation and vasoconstriction were further studied 
statistically, as shown in Fig. 41 (9 vessels for vasoconstriction and 15 vessels for 
vasodilatation). For each vessel, vasoconstriction or vasodilatation occurring at the lowest 
stimulation current was chosen for study. The unpaired 1-tailed Wilcoxon Signed Rank 
Test showed that the response and recovery times of vasodilatation were significantly 
longer than those of vasoconstriction. Interestingly, although both the response phase of 
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vasodilation and the recovery phase of vasoconstriction represent the increase in vessel 
diameter, their time scales are quite different (the same situation for the recovery phase of 
vasodilation and the response phase of vasoconstriction). This likely suggests the 
different underlying mechanisms of the two types of vascular response: vasoconstriction, 
caused by the reaction of the smooth muscle cells, is much faster than vasodilatation, 
which is caused by other types of slow-response cells in the blood vessel wall.149, 154 
 
Fig. 41. Temporal characteristics of vasoconstriction (9 vessels) and vasodilatation (15 
vessels). The response (rising/falling) time and recovery time of vasodilatation are 
compared with those of vasoconstriction, using the 1-tailed Wilcoxon Signed Rank Test. 
The response and recovery times of vasodilatation are statistically significantly longer 
than those of vasoconstriction (p values for both response and recovery cases are 0.005). 
 
Responses of individual microvessels in a mouse cortex to intracortical electrical 
stimulation were studied with OR-PAM. The relatively small fluctuation (±10%) in the 
baseline vessel diameter during each OR-PAM monitoring suggested that the 
neurovascular system remained at a resting state under consistent physiological 
conditions (Fig. 39). However, this balance could be broken down by electrical-
119 
 
stimulation-induced vasoconstriction or vasodilatation, depending on stimulation 
intensity and other factors. 
The dual reaction of some vessels to electrical stimulation suggests that 
vasoconstriction and vasodilatation result from different cellular regulations, which is 
consistent with the literature.150 The distinct spatial characteristics of vasoconstriction 
and vasodilatation (Fig. 40) suggest that vasoconstriction may be due to the direct 
stimulation of smooth muscle cells and thus decays rapidly with increased distance from 
the stimulation source, while vasodilatation mainly may result from metabolic regulation 
and shows a much weaker spatial dependence. The pronounced difference between the 
temporal features of vasoconstriction and vasodilatation (Fig. 41) reflects the different 
underlying mechanisms: vasoconstriction, caused by direct electrical stimulation of 
smooth muscle cells, is related to mechanical features of vessel walls and can be executed 
in a short time,143, 155 while vasodilatation, caused by the various neurotransmitters and 
neuromodulators, may take longer because of the relatively slow transmission speed of 
neuromodulator signals.  
 
2.4 Conclusion 
In summary, label-free OR-PAM was used to the spatial-temporal characteristics and 
current dependence of the microvascular response to cortical electrical stimulation. The 
high spatial resolution enables analyzing single vessel responses, and the large FOV 
allows simultaneous imaging of multiple microvessels for studying correlation and 
performing statistical analysis. OR-PAM is a promising tool for in vivo studies of 
neurovascular coupling at the microscopic level. 
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3. Longitudinal transcranial monitoring of ischemic stroke*
Ischemic stroke refers to the death of brain tissue resulting from an inadequate supply of 
blood and oxygen due to blockage of a major artery. As a result of ischemic stroke, the 
affected area of the brain is unable to function properly, which may lead to body paralysis, 
communication difficulty, or vision impairment. A major obstacle in understanding the 
underlying mechanism of stroke is the lack of an imaging tool to noninvasively or 
minimally invasively monitor cerebral hemodynamics, covering the entire span of the 
stroke period. 
 
As a preliminary study, transcranial OR-PAM longitudinally imaged the 
microvasculature and the vessel-by-vessel sO2 in an adult Swiss Webster mouse subject 
to a 40-min MCA occlusion (Fig. 42). OR-PAM observed that, during 40-min MCA 
occlusion, the average sO2 within arteries and veins dropped ~20% and ~45%, 
respectively. After reperfusion, the vessel sO2 recovered back to normal values. In 
contrast, the regional oxygen extraction fraction increased 41% during MCA occlusion, 
indicating that the stroke tissue was oxygen-starving (Table 5). 
 
Fig. 42. Longitudinal OR-PAM of MCA-occlusion-induced cerebral sO2 changes.  
 
                                                 
* S. Hu et. al., Preliminary data. 
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Table 5. Functional changes in cortical vasculature due to 40-min MCA occlusion. 
 Before (%) During (%) After (%) 
Average arterial sO2 93 76 91 
Average venous sO2 72 27 73 
Oxygen extraction fraction 23 64 20 
 
Future study will focus on longitudinal, transcranial monitoring of morphological 
(i.e., vessel diameter) and functional (i.e., HbT, sO2, and blood flow) changes in cortical 
vessels due to ischemic stroke induction. It will provide the unprecedented ability to 
study the intrinsic tissue mechanisms of ischemic brain injury and explore more effective 
neuroprotective therapies. 
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V. CONCLUSIONS AND PERSPECTIVES*
OR-PAM has potentially broad applications in biomedical imaging, yet much effort still 
needs to be invested to mature this technology. Three potential directions of future OR-
PAM development are anticipated: 
 
• Optical detection of photoacoustic waves. Current acoustic detection in OR-PAM 
is based on piezoelectric transducers, which require good tissue contact and generally 
involve water in acoustic coupling. This configuration leads to system complexity and 
experimental inconvenience. Moreover, the detection sensitivity of the transducer falls 
off with its element size. Higher detection frequency is achieved at the expense of SNR. 
To overcome these limitations, noncontact optical methods for ultrasonic detection need 
to be explored. 
• Integrating OR-PAM with AR-PAM for multi-scale imaging. As shown in Fig. 1, 
OR-PAM and AR-PAM are highly complementary in terms of spatial resolution and 
tissue penetration. Combining them together would enable users to select an optimal 
trade-off between the spatial resolution and the penetration depth for different 
applications. 
• Integrating OR-PAM with multiphoton fluorescence microscopy for 
neurovascular imaging. OR-PAM and multiphoton microscopy have similar penetration 
depths in soft brain tissues.5 Combining them would enable direct visualization of the 
interaction between neuron activities and vascular dynamics. 
                                                 
* Modified with permission from S. Hu, K. Maslov, and L. V. Wang, “Three-dimensional optical-
resolution photoacoustic microscopy,” in Biomedical Optical Imaging Techniques: Design and 
Applications, J. M. Zavislan and R. Liang, Ed., Springer (under review). 
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Being one of the most actively studied optical microscopy technologies, OR-PAM 
has experienced a dramatic development within the last few years. We are looking 
forward to seeing OR-PAM in the mainstream. 
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